| For: | Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2015; 21(37): 10573-10583 [PMID: 26457017 DOI: 10.3748/wjg.v21.i37.10573] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i37/10573.htm |
| Number | Citing Articles |
| 1 |
Sara Haj Ali, Shahd I Alqato, Amjad M Almansi, Noor S Haj Ali, Mohammad A Amaireh. Hepatocellular Carcinoma: The Search for an Optimal Screening Test. Middle East Journal of Digestive Diseases 2025; 17(1) doi: 10.34172/mejdd.2025.407
|
| 2 |
Weizhen Huang, Jun Li, Xiaohong Guo, Yingchu Zhao, Xia Yuan. miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2. Biomedicine & Pharmacotherapy 2016; 81 doi: 10.1016/j.biopha.2016.04.034
|
| 3 |
Ting Wang, Wen-Xue Chen, Guo-Feng Xu, Bei Zhang, Shu-Qin Wei, Jia Hu, Kun-He Zhang. A universal strategy designed for selecting bench-to-bedside aptamers to serum and validated in hepatocellular carcinoma diagnosis. Microchemical Journal 2019; 150 doi: 10.1016/j.microc.2019.104152
|
| 4 |
Shun Tamaki, Hiromasa Imaishi. Inhibitory effects of type 2 diabetes serum components in P450 inhibition assays can potential diagnose asymptomatic diabetic mice. Drug Metabolism and Pharmacokinetics 2020; 35(6) doi: 10.1016/j.dmpk.2020.07.003
|
| 5 |
Laura Guerrero, Alberto Paradela, Fernando J. Corrales. Targeted Proteomics for Monitoring One-Carbon Metabolism in Liver Diseases. Metabolites 2022; 12(9) doi: 10.3390/metabo12090779
|
| 6 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
| 7 |
Huixian Zhang, Hailong Li, Redha Ali, Wei Jia, Wen Pan, Scott B. Reeder, David Harris, William Masch, Anum Aslam, Krishna Shanbhogue, Nehal A. Parikh, Jonathan R. Dillman, Lili He. Development and Validation of a Modality-Invariant 3D Swin U-Net Transformer for Liver and Spleen Segmentation on Multi-Site Clinical Bi-parametric MR Images. Journal of Imaging Informatics in Medicine 2024; 38(5) doi: 10.1007/s10278-024-01362-w
|
| 8 |
Vaneet Jearth, Prachi S. Patil, Shaesta Mehta, Sridhar Sundaram, Vishal Seth, Mahesh Goel, Shraddha Patkar, Munita Bal, Vidya Rao. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken. Journal of Clinical and Experimental Hepatology 2022; 12(3) doi: 10.1016/j.jceh.2021.11.006
|
| 9 |
María Lola Espejo-Cruz, Sandra González-Rubio, Javier Zamora-Olaya, Víctor Amado-Torres, Rafael Alejandre, Marina Sánchez-Frías, Rubén Ciria, Manuel De la Mata, Manuel Rodríguez-Perálvarez, Gustavo Ferrín. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. International Journal of Molecular Sciences 2021; 22(23) doi: 10.3390/ijms222313073
|
| 10 |
Steven Alexander Mann, Romil Saxena. Predictive Biomarkers in Oncology. 2019; doi: 10.1007/978-3-319-95228-4_40
|
| 11 |
Diana Julie Leeming, Signe Holm Nielsen, Roslyn Vongsuvanh, Pruthviraj Uchila, Mette Juul Nielsen, Alexander L Reese-Petersen, David van der Poorten, Mohammed Eslam, Detlef Schuppan, Morten Asser Karsdal, Jacob George. Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma. Hepatic Oncology 2021; 8(2) doi: 10.2217/hep-2020-0030
|
| 12 |
Furong Liu, Zhibin Liao, Jia Song, Chaoyi Yuan, Yachong Liu, Hongwei Zhang, Yonglong Pan, Zhanguo Zhang, Bixiang Zhang. Genome‐wide screening diagnostic biomarkers and the construction of prognostic model of hepatocellular carcinoma. Journal of Cellular Biochemistry 2020; 121(3) doi: 10.1002/jcb.29480
|
| 13 |
Yan Jiao, Yanqing Li, Peiqiang Jiang, Zhuo Fu, Yahui Liu. High MAST2 mRNA expression and its role in diagnosis and prognosis of liver cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56476-x
|
| 14 |
Arely Rosas-Cruz, Nohemí Salinas-Jazmín, Marco A. Velasco- Velázquez. Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets?. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211027913
|
| 15 |
Yating Xu, Xiao Yu, Zongzong Sun, Yuting He, Wenzhi Guo. Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.831366
|
| 16 |
Zachary J. Brown, Tim F. Greten. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; doi: 10.1007/978-3-030-21540-8_12
|
| 17 |
Olfat Al-Harazi, Ibrahim H. Kaya, Maha Al-Eid, Lina Alfantoukh, Ali Saeed Al Zahrani, Mohammed Al Sebayel, Namik Kaya, Dilek Colak. Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.710049
|
| 18 |
Dan Wang, Xiaojing Zhang, Yapeng Lu, Xueting Wang, Li Zhu. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis. Pathology - Research and Practice 2018; 214(12) doi: 10.1016/j.prp.2018.09.007
|
| 19 |
Bita Moudi, Zahra Heidari, Hamidreza Mahmoudzadeh-Sagheb. The Study of Menin Expression as a Diagnostic Factor in HBV-Related Hepatocellular Carcinoma. Archives of Clinical Infectious Diseases 2020; 14(6) doi: 10.5812/archcid.88188
|
| 20 |
Zheng Li, Haijie Xu, Jiaming Yu, Cantong Liu, Chunwen Zheng, Ruijie Zeng, Liyan Xu, Enmin Li, Yuhui Peng, Yiwei Xu. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma. Cancer Control 2021; 28 doi: 10.1177/10732748211004883
|
| 21 |
Thomas Karlas, Valentin Blank, Albrecht Böhlig. Diagnostic Value of Ultrasound in Fatty Liver Disease. Ultraschall in der Medizin - European Journal of Ultrasound 2021; 42(02) doi: 10.1055/a-1352-4313
|
| 22 |
Benjamin Koh, Pojsakorn Danpanichkul, Meng Wang, Darren Jun Hao Tan, Cheng Han Ng. Application of artificial intelligence in the diagnosis of hepatocellular carcinoma. eGastroenterology 2023; 1(2) doi: 10.1136/egastro-2023-100002
|
| 23 |
Yin-Qiao Liu, Ling-Yu Chu, Tian Yang, Biao Zhang, Zheng-Tan Zheng, Jian-Jun Xie, Yi-Wei Xu, Wang-Kai Fang. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. Bioscience Reports 2022; 42(5) doi: 10.1042/BSR20212612
|
| 24 |
Jun Zhou, Gonghao Ling, Jia Cao, Xun Ding, Xingnan Liao, Meng Wu, Xinyu Zhou, Haibo Xu, QingYun Long. <p>Transcatheter Intra-Arterial Infusion Combined with Interventional Photothermal Therapy for the Treatment of Hepatocellular Carcinoma</p>. International Journal of Nanomedicine 2020; doi: 10.2147/IJN.S233989
|
| 25 |
Yanping Zhang, Wanwen Lao, Kaming Yang, Xinyi Kong, Yuetong Li, Xin Yu, Xumeng Wang, Yang Liu, Zhenlin Li, Yilin Deng, Shuping Nie, Changlong Bi, Chao Wu, Aixia Zhai. SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11633-4
|
| 26 |
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford, Chamindie Punyadeera. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2) doi: 10.1016/j.bbcan.2020.188451
|
| 27 |
Meiying Long, Zihan Zhou, Xueyan Wei, Qiuling Lin, Moqin Qiu, Yunxiang Zhou, Peiqin Chen, Yanji Jiang, Qiuping Wen, Yingchun Liu, Runwei Li, Xianguo Zhou, Hongping Yu. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1023349
|
| 28 |
Ying Li, Jingran Chen, Zhen Liu. Recent advances in molecularly imprinted glycan-binders and their biomedical applications. TrAC Trends in Analytical Chemistry 2026; 194 doi: 10.1016/j.trac.2025.118521
|
| 29 |
Quynh Hoa Tran, Van Gio Nguyen, Cong Manh Tran, Minh Nam Nguyen. Down-regulation of solute carrier family 10 member 1 is associated with early recurrence and poorer prognosis of hepatocellular carcinoma. Heliyon 2021; 7(3) doi: 10.1016/j.heliyon.2021.e06463
|
| 30 |
An‐Li Jin, Yi‐Hui Yang, Xi Su, Wen‐Jing Yang, Te Liu, Wei Chen, Tong Li, Lin Ding, Hao Wang, Bei‐Li Wang, Bai‐Shen Pan, Jian Zhou, Jia Fan, Xin‐Rong Yang, Wei Guo. High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2022; 36(3) doi: 10.1002/jcla.24259
|
| 31 |
Ema Elvira Herrera-López, Dafne Guerrero-Escalera, Isaac Aguirre-Maldonado, Arely López-Hernández, Hilda Montero, María Angélica Gutiérrez‐Nava, Luis del Pozo-Yauner, Jaime Arellanes-Robledo, Javier Camacho, Julio Isael Pérez-Carreón. Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34117-8
|
| 32 |
Craig C Teerlink, Chad Huff, Jeff Stevens, Yao Yu, Sheri L Holmen, Mark R Silvis, Kirby Trombetti, Hua Zhao, Douglas Grossman, James M Farnham, Jingran Wen, Julio C Facelli, Alun Thomas, Markus Babst, Scott R Florell, Laurence Meyer, John J Zone, Sancy Leachman, Lisa A Cannon-Albright. A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma. JNCI: Journal of the National Cancer Institute 2018; doi: 10.1093/jnci/djy058
|
| 33 |
Jung-Chen Ho, Meng-Lun Hsieh, Po-Heng Chuang, Vivian Chia-Rong Hsieh. Cost-Effectiveness of Sorafenib Monotherapy and Selected Combination Therapy with Sorafenib in Patients with Advanced Hepatocellular Carcinoma. Value in Health Regional Issues 2018; 15 doi: 10.1016/j.vhri.2017.12.012
|
| 34 |
Xiaogang Dong, Wei Ding, Jianwei Ye, Dong Yan, Feng Xue, Lin Xu, Jiwei Yin, Wenjia Guo. MiR‐24‐3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M. Cell Biochemistry and Function 2016; 34(7) doi: 10.1002/cbf.3213
|
| 35 |
Zhao Liu, Yapan Guo, Peng Wang, Shitao Lu, Ming-Ming Li, Zhi Li, Tongqing Xue. Prognostic value of alpha-fetoprotein and des-gamma-carboxyprothrombin in hepatocellular carcinoma treated with transarterial chemoembolization. Journal of Cancer Research and Therapeutics 2025; 21(6) doi: 10.4103/jcrt.jcrt_614_25
|
| 36 |
Simona Cernea, Danusia Onișor. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(2): 286-309 doi: 10.3748/wjg.v29.i2.286
|
| 37 |
Felice De Stefano, Eduardo Chacon, Lilia Turcios, Francesc Marti, Roberto Gedaly. Novel biomarkers in hepatocellular carcinoma. Digestive and Liver Disease 2018; 50(11) doi: 10.1016/j.dld.2018.08.019
|
| 38 |
Mu-Sheng Zeng. The Long and Short Non-coding RNAs in Cancer Biology. Advances in Experimental Medicine and Biology 2016; 927 doi: 10.1007/978-981-10-1498-7_15
|
| 39 |
N Hasan, M Mukim, P Sharma, U. S. Baghel, M. Khalid. CURRENT UPDATES ON DIAGNOSTIC BIOMARKERS OF HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 2019; 56(06) doi: 10.53879/id.56.06.11625
|
| 40 |
Yingying Lin, Yuefei Ma, Yan Chen, Yepei Huang, Jinchuan Lin, Zhenzhou Xiao, Zhaolei Cui. Diagnostic and prognostic performance of serum GPC3 and PIVKA-II in AFP-negative hepatocellular carcinoma and establishment of nomogram prediction models. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14025-y
|
| 41 |
Longgang Zhao, Xinyuan Zhang, Brenda M. Birmann, Christopher J. Danford, Michelle Lai, Tracey G. Simon, Andrew T. Chan, Edward L. Giovannucci, Long Ngo, Towia A. Libermann, Xuehong Zhang. Pre‐diagnostic plasma inflammatory proteins and risk of hepatocellular carcinoma in three population‐based cohort studies from the United States and the United Kingdom. International Journal of Cancer 2024; 155(9) doi: 10.1002/ijc.35054
|
| 42 |
Prognostic and Therapeutic Potentials of OncomiRs Modulating mTOR Pathways in Virus-Associated Hepatocellular Carcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.604540
|
| 43 |
Tao Li, Yuanzi Yu, Juan Liu, Xiangguo Tian, Meng Kong, Lei Wu, Shaocan Tang, Shengqing Gu, Jingfang Zhao, Yi Cui, Jinhua Hu. PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma. Infectious Agents and Cancer 2019; 14(1) doi: 10.1186/s13027-019-0229-6
|
| 44 |
Badriya Baig, Sulafa Abdel Halim, Aaminah Farrukh, Yaser Greish, Amr Amin. Current status of nanomaterial-based treatment for hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2019; 116 doi: 10.1016/j.biopha.2019.108852
|
| 45 |
Muthaiyan Ahalliya Rathi, Elliangal Kunhappa Girisan, Velliyur Kanniappan Gopalakrishnan, Periasamy Meenakshi, Dugganaboyana Guru Kumar. Nanomaterials for Energy Conversion, Biomedical and Environmental Applications. Materials Horizons: From Nature to Nanomaterials 2022; doi: 10.1007/978-981-19-2639-6_11
|
| 46 |
Li Huang, Zhuning Mo, Zuojian Hu, Linyan Zhang, Shanzi Qin, Xue Qin, Shan Li. Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-1161-y
|
| 47 |
Jishnu Ghosh, Abdullah M. Alshahrani, Aritra Palodhi, Debarghya Bhattacharyya, Subhadip Das, Sunil Kanti Mondal, Abul Kalam, S. Rehan Ahmad, Chittabrata Mal. Identification and therapeutic investigation of biomarker genes underpinning hepatocellular carcinoma: an in silico study utilising molecular docking and dynamics simulation. Frontiers in Bioinformatics 2025; 5 doi: 10.3389/fbinf.2025.1567748
|
| 48 |
Hu Liang, Ji Ai-Jun, Zhang Ji-Zong, Han Jian-Bo, Zhao Liang, Yi Yong-Xiang, Yu Chen. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma. Anti-Cancer Drugs 2019; 30(2) doi: 10.1097/CAD.0000000000000711
|
| 49 |
Ye Xu, Qinglong Guo, Libin Wei. The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma. Cancers 2021; 13(20) doi: 10.3390/cancers13205096
|
| 50 |
Zhipeng Tang, Pei Zhao, Wanxing Zhang, Qian Zhang, Ming Zhao, He Tan. SALL4 activates PI3K/AKT signaling pathway through targeting PTEN, thus facilitating migration, invasion and proliferation of hepatocellular carcinoma cells. Aging 2022; 14(24) doi: 10.18632/aging.204446
|
| 51 |
Jingnuo Ding, Weifeng Zhao. The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma. Cancer Management and Research 2022; doi: 10.2147/CMAR.S373165
|
| 52 |
Duan Xie, Dongxia Li, Fangrong Hu, Zhiyou Wang, Longhui Zhang, Mingzhu Jiang, Yuanli Wang. Terahertz Metamaterial Biosensor With Double Resonant Frequencies for Specific Detection of Early-Stage Hepatocellular Carcinoma. IEEE Sensors Journal 2023; 23(2) doi: 10.1109/JSEN.2022.3225344
|
| 53 |
Sami Akbulut, Cemil Colak. Explainable artificial intelligence and ensemble learning for hepatocellular carcinoma classification: State of the art, performance, and clinical implications. World Journal of Hepatology 2025; 17(11): 109494 doi: 10.4254/wjh.v17.i11.109494
|
| 54 |
Ting Wang, Kun-He Zhang, Piao-Ping Hu, Zeng-Yong Huang, Pan Zhang, Qin-Si Wan, De-Qiang Huang, Nong-Hua Lv. Simple and robust diagnosis of early, small and AFP-negative primary hepatic carcinomas: an integrative approach of serum fluorescence and conventional blood tests. Oncotarget 2016; 7(39) doi: 10.18632/oncotarget.11771
|
| 55 |
Devendra S. Shirode, Dinesh J. Raut, Nikita Sarasawat. Effect of Niosomal Encapsulation of Quercetin and Silymarin and their
Combination on Dimethylnitrosoamine-induced and Phenobarbital promoted
Hepatocellular Carcinoma in Rat Model. Current Drug Discovery Technologies 2024; 21(5) doi: 10.2174/0115701638278205231231153851
|
| 56 |
Egisto Boschetti, Alfonsina D'Amato, Giovanni Candiano, Pier Giorgio Righetti. Protein biomarkers for early detection of diseases: The decisive contribution of combinatorial peptide ligand libraries. Journal of Proteomics 2018; 188 doi: 10.1016/j.jprot.2017.08.009
|
| 57 |
Andem Effiong, Prerna Kumari. Pharmacotherapies for fatigue in chronic liver disease (CLD): a systematic review and meta-analysis (protocol). Systematic Reviews 2018; 7(1) doi: 10.1186/s13643-018-0688-7
|
| 58 |
Jing Li, Yi Ren, Guilin Zhang, Yusheng Guo, Suyue Wu, Weimin Zhao, Chuansheng Zheng, Lian Yang, Xuefeng Kan. Hepatic immune prognostic index as a prognostic biomarker in hepatocellular carcinoma patients treated with transarterial chemoembolization. Therapeutic Advances in Medical Oncology 2026; 18 doi: 10.1177/17588359261447986
|
| 59 |
Mona Moussa, Noha Helal, Enas Elnahas, Samar El-Sheikh, Dalal Alwi. Correlation of hepatic expression of Ki-67 and metallothionein with iron load in chronic hepatitis C and hepatocellular carcinoma. Current Medicine Research and Practice 2018; 8(6) doi: 10.1016/j.cmrp.2018.10.002
|
| 60 |
天柱 吴. Research Trends of Artificial Intelligence in Liver Cancer: A Bibliometric Analysis. Advances in Clinical Medicine 2023; 13(04) doi: 10.12677/ACM.2023.134907
|
| 61 |
Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Ying He, Magdalena Swiatek‐de Lange, David Morgenstern, Henry Lik‐Yuen Chan. Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study. Hepatology Communications 2022; 6(4) doi: 10.1002/hep4.1847
|
| 62 |
Jianzhu Luo, Jianhua Liang, Haixiang Xie, Jiaguang Chen, Xiaoqiang Shen, Fuquan Yang, Tianman Li. Evaluation and verification of MPDZ as a prognostic biomarker for hepatocellular carcinoma through multiple databases. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01729-5
|
| 63 |
Peter Murphy, David Glynn, Sofia Dias, Robert Hodgson, Lindsay Claxton, Lucy Beresford, Katy Cooper, Paul Tappenden, Kate Ennis, Alessandro Grosso, Kath Wright, Anna Cantrell, Matt Stevenson, Stephen Palmer. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework. Health Technology Assessment 2021; 25(76) doi: 10.3310/hta25760
|
| 64 |
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang, Hong-Wei Cheng. Engineering nanotheranostic strategies for liver cancer. World Journal of Gastrointestinal Oncology 2021; 13(10): 1213-1228 doi: 10.4251/wjgo.v13.i10.1213
|
| 65 |
Jingjing Zong, Zhe Fan, Yewei Zhang. <p>Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma</p>. Journal of Hepatocellular Carcinoma 2020; doi: 10.2147/JHC.S272762
|
| 66 |
Wenjing Sun, Xinmiao Zhao, Xinjia Zhao, Lingkai Meng, Mingliang Tang, Jiaqi Li, Yongxin Chang, Yuting Xiong, Hao Wang, Jinghua Chen, Guangyan Qing. Significantly enhanced capture efficiency of cell-imprinted material for circulating tumor cells via a flexible and ultra-strong double-armed phenylboronic acid design. Biomaterials 2025; 322 doi: 10.1016/j.biomaterials.2025.123397
|
| 67 |
Xueying Wang, Yangyu Zhang, Na Yang, Hua He, Xuerong Tao, Changgui Kou, Jing Jiang, Muhammad Hassham Hassan Bin Asad. Evaluation of the Combined Application of AFP, AFP‐L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta‐analysis. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/5087643
|
| 68 |
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani. An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians. Biomedicines 2023; 11(2) doi: 10.3390/biomedicines11020586
|
| 69 |
Shuping Zhou, Juan Wei, Yeliu Wang, Xinkuang Liu. Cisplatin resistance‑associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8526
|
| 70 |
Jyoti Baruah, Sthiti Porna Dutta, Partha Pratim Das, Jutishna Bora, Sumira Malik, Smita Lata, Sarvesh Rustagi, Pranav Kumar Prabhakar. The Potential of Cancer Biomarkers. 2025; doi: 10.1016/B978-0-443-29279-8.00001-6
|
| 71 |
Ke Su, Weihong Huang, Xueting Li, Ke Xu, Tao Gu, Yanlin Liu, Juan Song, Keyi Qian, Yaoyang Xu, Hao Zeng, Yipei Yang, Lu Guo, Yunwei Han. Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S398632
|
| 72 |
Jie Wu, Xi Li, Xiangbao Yin, Junwen Hu, Pengcheng Zhou, Xiaofeng Zhong, Mingming Wu. Rapid detection of plasma exosomal LncRNA CASC9 for HCC using RT-RPA-CRISPR/Cas12a assay. Journal of Pharmaceutical and Biomedical Analysis 2025; 266 doi: 10.1016/j.jpba.2025.117085
|
| 73 |
Ying Zhao, Jinmei Yao. The Biological Functions and Clinical Values of Exosomal Circular RNAs in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.885214
|
| 74 |
Muhammad Afzal, Muhammad Imran, Samen Fatima, Muhammad Iqbal, Farkhanda Gillani, Nayyar Rubab, Owais Gill, Muhammad Naeem. 99mTc-MDP renal parenchymal retention on bone scan in hepatocellular carcinoma patients. Pakistan Journal of Nuclear Medicine 2020; doi: 10.24911/PJNMed.175-1574674085
|
| 75 |
Jiaheng Zhu, Chenhongmei Wang, Tianhao Huang, Lihuang Zeng, Qiang Niu, Xinyue Huang, Hanyang Chen, Mengqi Jiang, Baichang Deng, Yiming Yan, Xiaohui Liu, Junjie Chen, Yinong Xie, Jiaqing Shen, Wei Chen, Yuan Gao, Kaibin Chen, Xiangyujie Lin, Lijun Zeng, Bo Li, Yanling Song, Jinfeng Zhu, Boan Li. Rapid Detection and Purification of Extracellular Vesicles for Hepatocellular Carcinoma Screening Using a Plasmonic Metasurface Integrated with the Kolmogorov–Arnold Network. ACS Nano 2025; 19(49) doi: 10.1021/acsnano.5c11740
|
| 76 |
Pengfei Li, Zhen Liu. Glycan-specific molecularly imprinted polymers towards cancer diagnostics: merits, applications, and future perspectives. Chemical Society Reviews 2024; 53(4) doi: 10.1039/D3CS00842H
|
| 77 |
AM Attallah, MS Albannan, MS El-Deen, K Farid, FM Khedr, KA Attallah, SO Abdallah. Diagnostic role of collagen-III and matrix metalloproteinase-1 for early detection of hepatocellular carcinoma. British Journal of Biomedical Science 2020; 77(2) doi: 10.1080/09674845.2019.1708534
|
| 78 |
Zeribe C. Nwosu, Nadia Battello, Melanie Rothley, Weronika Piorońska, Barbara Sitek, Matthias P. Ebert, Ute Hofmann, Jonathan Sleeman, Stefan Wölfl, Christoph Meyer, Dominik A. Megger, Steven Dooley. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0872-6
|
| 79 |
Wenhua Hu, Wei Ge, Peng Xia, Yan Chen, Jing Du, Guangxu Hu, Zhen Wu, Xumin Zhang, Chuanlai Yang, Junhong Jiang, Shuang Yang, Jun Xia. Diagnostic Potential of Serum Glycome Analysis in Lung Cancer: A Glycopattern Study. Journal of Proteome Research 2024; 23(1) doi: 10.1021/acs.jproteome.3c00645
|
| 80 |
Zhehan Shen, Lingzhi Chen, Lilong Wang, Shunjie Dong, Fakai Wang, Yaning Pan, Jiahao Zhou, Yikun Wang, Xinxin Xu, Huanhuan Chong, Huimin Lin, Weixia Li, Ruokun Li, Haihong Ma, Jing Ma, Yixing Yu, Lianjun Du, Xiaosong Wang, Shaoting Zhang, Fuhua Yan. An Explainable Deep Learning Model for Focal Liver Lesion Diagnosis Using Multiparametric MRI. Radiology: Artificial Intelligence 2025; 7(6) doi: 10.1148/ryai.240531
|
| 81 |
Qingqing Lv, Zhaoyu Zhang, Haijuan Fu, Danyang Li, Yihao Liu, Yingnan Sun, Minghua Wu. Predictive Panel for Immunotherapy in Low-Grade Glioma. World Neurosurgery 2024; 183 doi: 10.1016/j.wneu.2024.01.039
|
| 82 |
Maria Papanastasatou, Mihalis Verykokakis. Innate-like T lymphocytes in chronic liver disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1114605
|
| 83 |
Hyunsoo Kim, Areum Sohn, Injoon Yeo, Su Jong Yu, Jung-Hwan Yoon, Youngsoo Kim. Clinical Assay for AFP-L3 by Using Multiple Reaction Monitoring–Mass Spectrometry for Diagnosing Hepatocellular Carcinoma. Clinical Chemistry 2018; 64(8) doi: 10.1373/clinchem.2018.289702
|
| 84 |
Peng Liu, Jinhong Wei, Feiyu Mao, Zechang Xin, Heng Duan, Yan Du, Xiaodong Wang, Zhennan Li, Jianjun Qian, Jie Yao. Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.641487
|
| 85 |
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim. Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization. Cancers 2021; 14(1) doi: 10.3390/cancers14010067
|
| 86 |
Wentao Zhu, Pei Shi, An Liang, Ying Zhu, Jiwei Fu, Songsong Yuan, Xiaoping Wu. The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10139-9
|
| 87 |
Yinying Chen, Wei Yang, Qilong Chen, Qiong Liu, Jun Liu, Yingying Zhang, Bing Li, Dongfeng Li, Jingyi Nan, Xiaodong Li, Huikun Wu, Xinghua Xiang, Yehui Peng, Jie Wang, Shibing Su, Zhong Wang. Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02791-9
|
| 88 |
Ahmed Musa Hago Bakheet, Chang Zhao, Jian-Ning Chen, Jing-Yue Zhang, Jun-Ting Huang, Yu Du, Li-Ping Gong, Yuan-Hua Bi, Chun-Kui Shao. Improving pathological early diagnosis and differential biomarker value for hepatocellular carcinoma via RNAscope technology. Hepatology International 2020; 14(1) doi: 10.1007/s12072-019-10006-z
|
| 89 |
Jialu Weng, Shiyi Wu, Yating Pan, Yifan Lai, Jinrong Zhu, Wenzhang Jin, Deyu Lu, Yizhang Chen, Zhijie Yu, Xinjie Zan, Jinglin Xia. PH-sensitive adriamycin hydrochloride and oxaliplatin dual-loaded microspheres synergistically enhance local injections effect of hepatocellular carcinoma. Materials Today Bio 2024; 29 doi: 10.1016/j.mtbio.2024.101311
|
| 90 |
Wenya Xing, Yuanzi Zhou, Qiuzi Long, Nan Yi, Gaoyuan Wang, Rongwei Shi, Jinlong Huang, Xindong Yin, Taiyang Zhu, Shibing Cao. Multiomic analysis of lactylation and mitochondria-related genes in hepatocellular carcinoma identified MRPL3 as a new prognostic biomarker. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1511958
|
| 91 |
Yanan Xu, Shanshan Zhang, Guozheng Wei, Yang Lv, Lefan Dai, Cui Li, Mingming Wang. UTP3: A Prognostic Marker in Hepatocellular Carcinoma and Its Role in Immunity and Epigenetics. Journal of Biochemical and Molecular Toxicology 2025; 39(12) doi: 10.1002/jbt.70632
|
| 92 |
Audrey Payancé, Marco Dioguardi Burgio, Katell Peoc’h, Mohamed Achahboun, Miguel Albuquerque, Julie Devictor, Hélène Chor, Hana Manceau, Olivier Soubrane, François Durand, Laurent Castera, Mohamed Bouattour, Valérie Paradis. Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2020; 32(10) doi: 10.1097/MEG.0000000000001652
|
| 93 |
Lihua Lyu, Wenjing Yang, Jiayi Yao, Hao Wang, Jie Zhu, Anli Jin, Te Liu, Beili Wang, Jian Zhou, Jia Fan, Xinrong Yang, Wei Guo.
The Diagnostic Value of Plasma Exosomal
HSA_CIRC_0070396
for Hepatocellular Carcinoma
. Biomarkers in Medicine 2021; 15(5) doi: 10.2217/bmm-2020-0476
|
| 94 |
Anthony Pellicano, Stephanie Mullan, Itzhak Goldberg, Prakash Narayan. Hepatic mRNA Expression Levels of the Oncogenes Alpha-Fetoprotein and Osteopontin as Diagnostics for Liver Cancer in a Murine Model of Diet-Induced Non-Alcoholic Steatohepatitis. Processes 2021; 9(9) doi: 10.3390/pr9091516
|
| 95 |
Tatiana de Almeida Simão, Jennifer Vieira Gomes, Diego José Gomes de Paula, Suzana Pinheiro de Oliveira Ribeiro. Molecular Diagnostics - Current Approaches and Their Clinical Applications. 2025; doi: 10.5772/intechopen.1009980
|
| 96 |
Won-Suk Song, Han-Gyu Park, Da-Hee Ann, Yoon-Yi Jeong, Mi-Young Koo, Yun-Gon Kim. Quantitative Analysis of Core-Fucosylated N-glycome according to Serum AFP Level for the Diagnosis of Hepatocellular Carcinoma. KSBB Journal 2017; 32(4) doi: 10.7841/ksbbj.2017.32.4.279
|
| 97 |
Thanikan Sukaram, Rossarin Tansawat, Chonlada Phathong, Rungsun Rerknimitr, Roongruedee Chaiteerakij. Volatile organic compounds for diagnosis of early hepatocellular carcinoma in at-risk patients. Clinica Chimica Acta 2024; 556 doi: 10.1016/j.cca.2024.117831
|
| 98 |
Asma Sindhoo, Saima Sipy, Abbas Khan, Gurudeeban Selvaraj, Abdulrahman Alshammari, Mark Earl Casida, Dong-Qing Wei. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer. Database 2023; 2023 doi: 10.1093/database/baad063
|
| 99 |
Hao Li, Fei Li, Bo-Shen Wang, Bao-Li Zhu. Prognostic significance of exportin-5 in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(7): 3069-3081 doi: 10.4251/wjgo.v16.i7.3069
Abstract(566) |
Core Tip(568) |
Full Article(HTML)(1678)
|
Full Article (PDF)-6757K(156)
|
Full Article with Cover (PDF)-7045K(266)
|
Full Article (XML)-88K(133)
|
Audio-212K(26)
|
Peer-Review Report-319K(129)
|
Answering Reviewers-77K(100)
|
Supplementary Material-1124K(119)
|
Times Cited (3)
|
Total Visits (2630)
|
Open
|
| 100 |
Lijie Zhang, Joyman Makamure, Dan Zhao, Yiming Liu, Xiaopeng Guo, Chuansheng Zheng, Bin Liang. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV‑associated hepatocellular carcinoma. Experimental and Therapeutic Medicine 2020; 20(1) doi: 10.3892/etm.2020.8722
|
| 101 |
Yifan Wang, Linling Ju, Feng Xiao, Hui Liu, Xi Luo, Lin Chen, Zhonghua Lu, Zhaolian Bian. Downregulation of nucleolar and spindle‑associated protein 1 expression suppresses liver cancer cell function. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7314
|
| 102 |
Mira Anne C. dela Rosa, Wei-Chun Chen, Yi-Ju Chen, Rofeamor P. Obena, Chih-Hsiang Chang, Rey Y. Capangpangan, Tung-Hung Su, Chi-Ling Chen, Pei-Jer Chen, Yu-Ju Chen. One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature. Analytical Chemistry 2017; 89(7) doi: 10.1021/acs.analchem.6b04396
|
| 103 |
Daniela Sciancalepore, Maria Teresa Zingaro, Chiara Valentina Luglio, Carlo Sabbà, Nicola Napoli. Hepatocellular Carcinoma: Known and Emerging Risk Factors. Journal of Cancer Therapy 2018; 9(05) doi: 10.4236/jct.2018.95037
|
| 104 |
Feng Gao, Rui Zhang, Fang Ma, Bo Liu, Meng Zhang, Jihong Yang. Synthesis, characterization and application of ZnO and Ag-doped ZnO nanostructures against human liver cells (HepG2). A suitable candidate for valproate. Chemical Papers 2021; 75(5) doi: 10.1007/s11696-020-01456-z
|
| 105 |
Yang Han, Zhe Li, Qi Wu, Hui Liu, Zhiqiang Sun, Yong Wu, Judong Luo. B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09442-2
|
| 106 |
Satoyoshi Yamashita, Akira Kato, Toshitaka Akatsuka, Takashi Sawada, Tomohide Asai, Noriyuki Koyama, Kiwamu Okita. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(13): 1463-1473 doi: 10.3748/wjg.v26.i13.1463
|
| 107 |
P. Gunasekhar, S. Vijayalakshmi. Optimal biomarker selection using adaptive Social Ski-Driver optimization for liver cancer detection. Biocybernetics and Biomedical Engineering 2020; 40(4) doi: 10.1016/j.bbe.2020.10.005
|
| 108 |
Li-Yang Sun, Nan-Ya Wang, Yong-Kang Diao, Cun-Lin Yan, Zhu-Ping Fan, Lian-Hua Wei, Hui-Jun Li, Ming-Cheng Guan, Ming-Da Wang, Timothy M Pawlik, Wan Yee Lau, Feng Shen, Guo-Yue Lv, Tian Yang. Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score. Hepatobiliary & Pancreatic Diseases International 2025; 24(4) doi: 10.1016/j.hbpd.2023.12.004
|
| 109 |
Mohamed S. Attia, Amal A. Mohamed, Mostafa M. El-Saady, Mona N. Abou-Omar, Hisham G. Afify, Tarek A. Amin, Ahmed H. Hosny, Ahmed O. Youssef, Mohamed S. Mohy-Eldin. A new method for early diagnosis of liver cancer using a biosensor embedded in an alginate polymer thin film. Journal of Materials Chemistry C 2022; 10(16) doi: 10.1039/D2TC00209D
|
| 110 |
Erick Thokerunga, Peter Kisembo, Huang FangFang, Wang Zi, Zhang Yu, Christian Cedrick Bongolo, Jiancheng Tu. Serum Midkine for AFP-negative hepatocellular carcinoma diagnosis: a systematic review and meta-analysis. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00259-7
|
| 111 |
Rui Duan, Caiyan Li, Fan Wang, Fei Han, Ling Zhu. <p>The Long Noncoding RNA ZFAS1 Potentiates the Development of Hepatocellular Carcinoma via the microRNA-624/MDK/ERK/JNK/P38 Signaling Pathway</p>. OncoTargets and Therapy 2020; doi: 10.2147/OTT.S246278
|
| 112 |
Sivesh K. Kamarajah, Timothy L. Frankel, Christopher Sonnenday, Clifford S. Cho, Hari Nathan. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis. Journal of Surgical Oncology 2018; 117(4) doi: 10.1002/jso.24908
|
| 113 |
Rehab M. Golam, Mahmoud A. F. Khalil, Olfat G. Shaker, Tarek I. Ahmed, Mohamed K. Abd Elguaad, Essam A. Hassan, Mahmoud R. M. El-Ansary, Ahmed Ismail, Yasser I. Kandil, Osama A. Mohammed, Ahmed S. Doghish, Bruno Bernardes de Jesus. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma. PLOS ONE 2024; 19(5) doi: 10.1371/journal.pone.0303314
|
| 114 |
Ran Xue, Jiliang Feng, Qinghua Meng, Fudong Lv, Yueke Zhu, Hongwei Yu, Shijie Zhang, Chenzhao Song, Lin Sun, Zhujun Yue, Shuai Feng, Ruiwen Che, Qian Xiang, Xiaodan Jing. The significance of glypican‐3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression. Journal of Gastroenterology and Hepatology 2017; 32(8) doi: 10.1111/jgh.13736
|
| 115 |
Shuo Zhu, Shengya Cao, Weibin Yang, Jinhui Che, Deqiang Li, Ruifeng Pei, Yiren Ding. The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1. Cancer Management and Research 2021; doi: 10.2147/CMAR.S304125
|
| 116 |
Haixiang Xie, Chongjiu Qin, Xin Zhou, Junqi Liu, Kejian Yang, Jusen Nong, Jianzhu Luo, Tao Peng. Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma. Medicine 2023; 102(33) doi: 10.1097/MD.0000000000034765
|
| 117 |
Ziheng Zhan. Targeted Oncolytic Therapy for Hepatocellular Carcinoma with High Specificity and Efficiency. Highlights in Science, Engineering and Technology 2025; 144 doi: 10.54097/m1rfb241
|
| 118 |
Habiba M. Ismail, Abdelrahman A. Attia, Amr Abdelaal, Rana A. Youness. MIAT, HEIH, and HOTAIR: A novel LncRNA signature in non-metastatic hepatocellular carcinoma patients. Current Molecular Pharmacology 2025; 18(1) doi: 10.1016/j.cmp.2025.11.002
|
| 119 |
Xiaoyun Bin, Yu Luo, Zefeng Sun, Chaoqun Lin, Peng Huang, Zhenbo Tu, Ling Li, Cong Qu, Jiamin Long, Sufang Zhou. The Role of H2-Calponin Antigen in Cancer Metastasis: Presence of Autoantibodies in Liver Cancer Patients. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms24129864
|
| 120 |
Yixi Li, Zhimou Mei, Liang Shi, Yin Wan, Xiaoli Zhou, Ting Zeng, Yi Liu, Jia Yao Yang, Zhaohong Shi. RETRACTED: Evaluation of bevacizumab biosimilar on wound healing complications in patients with colorectal cancer undergoing endoscopic mucosal resection: A systematic review and meta‐analysis in anorectal medicine. International Wound Journal 2024; 21(1) doi: 10.1111/iwj.14638
|
| 121 |
Raja Chinnappan, Tariq Makhzoum, Momo Arai, Amro Hajja, Farah Abul Rub, Ibrahim Alodhaibi, Mohammed Alfuwais, Muhammad Affan Elahi, Eman Abdullah Alshehri, Lohit Ramachandran, Naresh Kumar Mani, Shugufta Abrahim, Mohammad Shabab Mir, Khaled Al-Kattan, Tanveer Ahmad Mir, Ahmed Yaqinuddin. Recent Advances in Biosensor Technology for Early-Stage Detection of Hepatocellular Carcinoma-Specific Biomarkers: An Overview. Diagnostics 2024; 14(14) doi: 10.3390/diagnostics14141519
|
| 122 |
De-Ling Wu, Zhen-Dong Liao, Fang-Fang Chen, Wei Zhang, Ya-Shuo Ren, Can-Can Wang, Xiao-Xiao Chen, Dai-Yin Peng, Ling-Yi Kong. Benzophenones from Anemarrhena asphodeloides Bge. Exhibit Anticancer Activity in HepG2 Cells via the NF-κB Signaling Pathway. Molecules 2019; 24(12) doi: 10.3390/molecules24122246
|
| 123 |
Diana Gabriela Domínguez-Lazcano. Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma. International Journal of Clinical and Experimental Pathology 2024; 17(11) doi: 10.62347/QSII4050
|
| 124 |
Zhaobin Xu, Xinling Wang, Wenyao Li, Wenjie Yang, Na Xu, Yushi Chen, Shengnan Luo, Fang Ma, Huiping Chen, Can Wang, Liguo Zhang. Detection of Four Early Tumor Biomarkers Using Micron-Sized Silica Microspheres Encoded With QDs (CQDs) for Tumor Early Screening. Journal of Fluorescence 2025; 36(2) doi: 10.1007/s10895-025-04619-x
|
| 125 |
Bingbing Shang, Ruohan Wang, Haiyan Qiao, Xixi Zhao, Liang Wang, Shaoguang Sui. Multi-omics analysis of pyroptosis regulation patterns and characterization of tumor microenvironment in patients with hepatocellular carcinoma. PeerJ 2023; 11 doi: 10.7717/peerj.15340
|
| 126 |
Yilong Zhou, Fan Liu, Chunyang Ma, Qiong Cheng. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2022; 36(10) doi: 10.1002/jcla.24673
|
| 127 |
Hao Xing, Cunling Yan, Liming Cheng, Nianyue Wang, Shuyang Dai, Jianyong Yuan, Wenfeng Lu, Zhouchong Wang, Jun Han, Yijie Zheng, Tian Yang. Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma. Tumor Biology 2016; 37(12) doi: 10.1007/s13277-016-5443-x
|
| 128 |
Jyoti Rajpoot, Manjula Jain, Mukta Pujani, Charu Agarwal, Ruchira Wadhwa, Monica Sarohi. Pediatric hepatocellular carcinoma in a 14-year-old boy: A rare case report. Journal of Cancer Research and Therapeutics 2024; 20(5) doi: 10.4103/jcrt.jcrt_1769_22
|
| 129 |
Liyan Wang, Bin Li, Xiaotong Bo, Xiaoyuan Yi, Xuhua Xiao, Qinghua Zheng. Hypoxia-induced LncRNA DACT3-AS1 upregulates PKM2 to promote metastasis in hepatocellular carcinoma through the HDAC2/FOXA3 pathway. Experimental & Molecular Medicine 2022; 54(6) doi: 10.1038/s12276-022-00767-3
|
| 130 |
Chaokun Yan, Mengyuan Li, Zhihao Suo, Jun Zhang, Jianlin Wang, Ge Zhang, Wenjuan Liang, Huimin Luo. Biomarkers Identification of Hepatocellular Carcinoma Based on Multiomics
Data Integration and Graph-embedded Deep Neural Network. Current Bioinformatics 2023; 18(6) doi: 10.2174/1574893618666230227122331
|
| 131 |
Katarzyna Lubecka, Kirsty Flower, Megan Beetch, Jay Qiu, Lucinda Kurzava, Hannah Buvala, Adam Ruhayel, Samer Gawrieh, Suthat Liangpunsakul, Tracy Gonzalez, George McCabe, Naga Chalasani, James M Flanagan, Barbara Stefanska. Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development. Epigenetics 2018; 13(6) doi: 10.1080/15592294.2018.1481706
|
| 132 |
Lei Zhang, Rong Hu, Yanyong Cheng, Xiaoyang Wu, Siwei Xi, Yu Sun, Hong Jiang. Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A. Cell Proliferation 2017; 50(5) doi: 10.1111/cpr.12364
|
| 133 |
Nurbubu Moldogazieva, Innokenty Mokhosoev, Sergey Zavadskiy, Alexander Terentiev. Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine. Biomedicines 2021; 9(2) doi: 10.3390/biomedicines9020159
|
| 134 |
Alireza Tojjari, James Yu, Anwaar Saeed. Immunotherapy and Radiation Therapy Combinatorial Approaches in Hepatocellular Carcinoma. Cancers 2024; 16(5) doi: 10.3390/cancers16051058
|
| 135 |
Agnieszka Lembas, Tomasz Mikuła, Magdalena Suchacz, Joanna Kozłowska, Szymon Barczak, Barbara Badura, Alicja Wiercińska-Drapało. Normal Glypican-3 Serum Levels Do Not Eliminate the Risk of Hepatocellular Carcinoma. Galician Medical Journal 2024; 31(4) doi: 10.21802/e-GMJ2024-A22
|
| 136 |
Pengfei Li, Jilei Pang, Shuxin Xu, Hui He, Yanyan Ma, Zhen Liu. A Glycoform‐Resolved Dual‐Modal Ratiometric Immunoassay Improves the Diagnostic Precision for Hepatocellular Carcinoma. Angewandte Chemie International Edition 2022; 61(21) doi: 10.1002/anie.202113528
|
| 137 |
Hong Wu, Yiqiang Liu, Qianshi Liu, Zhaoshen Li, Yejian Wan, Chenhui Cao, Binghuo Wu, MingXin Liu, Renchuan Liang, Lanlin Hu, Wenyi Zhang, Mei Lan, Quan Yao, Hang Zhou, Haitao Lan, Liang Chen, Yu Zhang, Xia Zhang, Xiu-Wu Bian, Chuan Xu. HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing. Science Advances 2024; 10(23) doi: 10.1126/sciadv.adl6083
|
| 138 |
Yong Liang, Zhen Liu, Dongliang Zuo, Shi Chen, Jianbin Chen, Xiaowen Yan, Pingguo Liu, Qiuquan Wang. Single cell glycan-linkages profiling for hepatocellular carcinoma early diagnosis using lanthanide encoded bacteriophage MS2 based ICP-MS. Talanta 2024; 274 doi: 10.1016/j.talanta.2024.126056
|
| 139 |
Rahul Agarwal, Jitendra Narayan, Amitava Bhattacharyya, Mayank Saraswat, Anil Kumar Tomar. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets. Cancer Genetics 2017; doi: 10.1016/j.cancergen.2017.06.002
|
| 140 |
Hanyao Sun, Wei Yang, Weizhong Zhou, Chungao Zhou, Sheng Liu, Haibin Shi, Wei Tian. Prognostic value of des‑γ‑carboxyprothrombin in patients with AFP‑negative HCC treated with TACE. Oncology Letters 2022; 25(2) doi: 10.3892/ol.2022.13655
|
| 141 |
Xiaoyu Jiang, Mary Kay Washington, Manhal J. Izzy, Ming Lu, Xinqiang Yan, Zhongliang Zu, John C. Gore, Junzhong Xu. Distinguishing Hepatocellular Carcinoma from Cirrhotic Regenerative Nodules Using MR Cytometry. Cancers 2025; 17(7) doi: 10.3390/cancers17071204
|
| 142 |
Yameng Zhang, Yufei Gao, Youhe Gao. Early changes in the urine proteome in a rat liver tumour model. PeerJ 2020; 8 doi: 10.7717/peerj.8462
|
| 143 |
Maryam Sadat Abtahi, Alireza Fotouhi, Niloufar Rezaei, Hilal Akalin, Yusuf Ozkul, Nikoo Hossein-Khannazer, Massoud Vosough. Nano-based drug delivery systems in hepatocellular carcinoma. Journal of Drug Targeting 2024; 32(9) doi: 10.1080/1061186X.2024.2365937
|
| 144 |
Lv Xiaorong, Fang Nie, Nan Wang, Rong Yang, Yuanqing Zhang, Guo Chen, Ran Zheng. Contrast-enhanced ultrasound for precise differentiation of hepatitis-related intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Abdominal Radiology 2026; doi: 10.1007/s00261-026-05401-8
|
| 145 |
Zhenhua Zhang, Qingchao Li, Xin Du, Min Liu. Application of electrochemical biosensors in tumor cell detection. Thoracic Cancer 2020; 11(4) doi: 10.1111/1759-7714.13353
|
| 146 |
Qinghua Zhu, Qingqing Huang, Xiaohua He, Miaomiao Jiang, Junkai Fu, Chenyuan Ding. Prognostic Relevance of MDK and TIMP1 with Immune Infiltration in Lung Adenocarcinoma. International Archives of Allergy and Immunology 2025; 187(3) doi: 10.1159/000547102
|
| 147 |
Marwa Matboli, Gouda I. Diab, Maha Saad, Abdelrahman Khaled, Marian Roushdy, Marwa Ali, Hind A. ELsawi, Ibrahim H. Aboughaleb. Machine-Learning-Based Identification of Key Feature RNA-Signature Linked to Diagnosis of Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2024; 14(6) doi: 10.1016/j.jceh.2024.101456
|
| 148 |
Li He, Wan-Sheng Ji, Hai-Long Jin, Wen-Jing Lu, Yuan-Yuan Zhang, Hua-Guang Wang, Yu-Yu Liu, Shuang Qiu, Meng Xu, Zi-Peng Lei, Qian Zheng, Xiao-Li Yang, Qing Zhang. Development of a nomogram for predicting liver transplantation prognosis in hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(21): 2763-2776 doi: 10.3748/wjg.v30.i21.2763
Abstract(723) |
Core Tip(711) |
Full Article(HTML)(3161)
|
Full Article (PDF)-2655K(206)
|
Full Article with Cover (PDF)-3999K(223)
|
Full Article (XML)-151K(137)
|
Audio-754K(32)
|
Peer-Review Report-321K(130)
|
Answering Reviewers-67K(137)
|
Supplementary Material-72K(138)
|
Times Cited (3)
|
Total Visits (4704)
|
Open
|
| 149 |
Yanhui Shi, Hongli Yang, Xue Bai, Xiaoyan Liu, Qiang Li, Wenjun Du. Female and diabetes are risk factors for alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II negative in hepatocellular carcinoma. Medicine 2024; 103(42) doi: 10.1097/MD.0000000000040100
|
| 150 |
Pengfei Li, Jilei Pang, Shuxin Xu, Hui He, Yanyan Ma, Zhen Liu. A Glycoform‐Resolved Dual‐Modal Ratiometric Immunoassay Improves the Diagnostic Precision for Hepatocellular Carcinoma. Angewandte Chemie 2022; 134(21) doi: 10.1002/ange.202113528
|
| 151 |
Jian-Xu Rao, Ying Li, Kai Leng. Artificial intelligence in hepatocellular carcinoma screening: applications and challenges. Frontiers in Medicine 2026; 12 doi: 10.3389/fmed.2025.1713887
|
| 152 |
W.B. Coleman, G.J. Tsongalis. Diagnostic Molecular Pathology. 2017; doi: 10.1016/B978-0-12-800886-7.00001-7
|
| 153 |
Jiu Chen, Guolin Wu, Youdi Li. Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis. Disease Markers 2018; 2018 doi: 10.1155/2018/8906023
|
| 154 |
Mona Samy Awed, Abeer Ibrahim, Omnia Ezzat, Amal Fawzy, Deema Kamal Sabir, Abdullah F. Radwan. Preliminary Evaluation of Plasma circ_0009910, circ_0027478, and miR-1236-3p as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2025; 26(10) doi: 10.3390/ijms26104842
|
| 155 |
Xiao-Hong Ma, Kun Chen, Shuang Wang, Si-Yun Liu, Deng-Feng Li, Yong-Tao Mi, Zhi-Yuan Wu, Chun-Feng Qu, Xin-Ming Zhao. Bi-specific T1 positive-contrast-enhanced magnetic resonance imaging molecular probe for hepatocellular carcinoma in an orthotopic mouse model. World Journal of Gastrointestinal Oncology 2022; 14(4): 858-871 doi: 10.4251/wjgo.v14.i4.858
|
| 156 |
Weiwei Qin, He Huang, Yuting Dai, Wei Han, Youhe Gao. Proteome analysis of urinary biomarkers in a cigarette smoke-induced COPD rat model. Respiratory Research 2022; 23(1) doi: 10.1186/s12931-022-02070-1
|
| 157 |
Andrew T. DelaCourt, Anand S. Mehta. Comprehensive Pharmacology. 2022; doi: 10.1016/B978-0-12-820472-6.00007-4
|
| 158 |
Long Zhao, Chao Xie, Danqing Liu, Tong Li, Yu Zhang, Chidan Wan. Early Detection of Hepatocellular Carcinoma in Patients with Hepatocirrhosis by Soluble B7-H3. Journal of Gastrointestinal Surgery 2017; 21(5) doi: 10.1007/s11605-017-3386-1
|
| 159 |
Qingwen Deng, Junhong Lu, Zhichao Zeng, Yuhang Zheng, Wenbin Liu. Dynamics of Health Technology Diffusion in the Integrated Care System (DHTDICS): A Development and Validation Study in China. Risk Management and Healthcare Policy 2021; doi: 10.2147/RMHP.S293144
|
| 160 |
Yeon Seok Seo, Kwan Soo Byun, Jong Eun Yeon, Yoon Tae Jeen, Hyung Joon Yim, Hyunggin An, Ji Hoon Kim, Young Kul Jung, Young-Sun Lee, Yoo Ra Lee, Han Ah Lee. <i>Lens culinaris</i> agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma. World Journal of Gastroenterology 2021; 27(28): 4687-4696 doi: 10.3748/wjg.v27.i28.4687
|
| 161 |
Yongjun Zhang, Mingyu Cheng, Yaxin Wang, Jian Zhang, Zhong Hua. A SERS biosensor regulated by tilt angle: an immunochip for α-fetoprotein. Journal of Materials Science 2021; 56(32) doi: 10.1007/s10853-021-06490-0
|
| 162 |
Mohamed Eissa, Selmy Awad, Somaya Barakat, Ahmed Saleh, Salah Rozaik. Serum Golgi protein 73 as a sensitive biomarker for early detection of hepatocellular carcinoma among Egyptian patients with hepatitis C virus-related cirrhosis. Medical Journal Armed Forces India 2021; 77(3) doi: 10.1016/j.mjafi.2020.11.013
|
| 163 |
Jin Jin, Xujun Liang, Wu Bi, Ruijie Liu, Sai Zhang, Yi He, Qingming Xie, Shilei Liu, Ji-Chang Xiao, Pengfei Zhang. Identification of a Difluorinated Alkoxy Sulfonyl Chloride as a Novel Antitumor Agent for Hepatocellular Carcinoma through Activating Fumarate Hydratase Activity. Pharmaceuticals 2023; 16(12) doi: 10.3390/ph16121705
|
| 164 |
Jingzhe Jin, Mingcheng Ren. The biological function of miR-128-2 in hepatocellular carcinoma and its molecular mechanism functioning. Pathology - Research and Practice 2024; 254 doi: 10.1016/j.prp.2024.155178
|
| 165 |
维康 伍. Study on the Application Value of α-Fetoprotein Household Test Paper (Aifupei) in a High Risk Group of Liver Cancer. Advances in Clinical Medicine 2023; 13(01) doi: 10.12677/ACM.2023.131015
|
| 166 |
You-Li Wang, Xiao-Sheng Ding, Guo-Xin Zhang. Prognostic model of hepatocellular carcinoma based on cancer grade. World Journal of Clinical Cases 2023; 11(27): 6383-6397 doi: 10.12998/wjcc.v11.i27.6383
Abstract(777) |
Core Tip(684) |
Full Article(HTML)(1621)
|
Full Article (PDF)-5625K(175)
|
Full Article with Cover (PDF)-5919K(272)
|
Full Article (Word)-3767K(40)
|
Full Article (XML)-92K(153)
|
Audio-2207K(10)
|
Peer-Review Report-343K(148)
|
Answering Reviewers-140K(150)
|
Times Cited (2)
|
Total Visits (3276)
|
Open
|
| 167 |
Sufang Wang, Michael Gribskov. Transcriptome analysis identifies metallothionein as biomarkers to predict recurrence in hepatocellular cacinoma. Molecular Genetics & Genomic Medicine 2019; 7(6) doi: 10.1002/mgg3.693
|
| 168 |
Jing Tang, Bo Yan, Gao-Feng Li, Qiu-Yu Li, Wen-Feng Liu, Rong-Bin Liang, Qian-Min Ge, Yi Shao. Carbohydrate antigen 125, carbohydrate antigen 15–3 and low-density lipoprotein as risk factors for intraocular metastases in postmenopausal breast cancer. Medicine 2021; 100(43) doi: 10.1097/MD.0000000000027693
|
| 169 |
ZHONGBAO ZHANG, GUANGJU MENG, LIANG WANG, YINGYING MA, ZHONGZHENG GUAN. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma. Molecular Medicine Reports 2016; 14(1) doi: 10.3892/mmr.2016.5261
|
| 170 |
Samuel Achilefu, Ramesh Raghavachari, Qi Zhang, Zhihao Han, Wancun Zhang, Zhiyu Qian, Yueqing Gu.
In vivo imaging of hepatocellular carcinoma using a glypican-3-binding peptide based probe
. Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications IX 2017; 10079 doi: 10.1117/12.2251310
|
| 171 |
Xiuzhi Zhang, Zhefeng Xiao, Xia Zhang, Ningning Li, Tao Sun, JinZhong Zhang, Chunyan Kang, Shasha Fan, Liping Dai, Xiaoli liu. Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03242-3
|
| 172 |
M. S. Chesnokov, O. M. Krivtsova, P. A. Skovorodnikova, A. S. Makarova, I. F. Kustova, M. D. Logacheva, A. A. Penin, A. V. Klepikova, D. A. Shavochkina, N. E. Kudashkin, E. A. Moroz, Y. I. Patyutko, E. A. Kotelnikova, N. L. Lazarevich. Transcriptome-based identification of PDGFA as a candidate secreted biomarker for hepatocellular carcinoma. Biopolymers and Cell 2016; 32(6) doi: 10.7124/bc.000939
|
| 173 |
Xi-Dai Long, Wei-Zhong Tang, Jun Lu, Xiao-Ying Huang, Jin-Guang Yao, Tian-Qi Zhang, Xing-Zhizi Wang, Qun-Ying Su, Chun-Ying Luo, Xue-Ming Wu, Chao Wang, Li-Xia Zeng, Qiang Xia, Yun Ma. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.72276
|
| 174 |
Sven H. Loosen, Mirco Castoldi, Markus S. Jördens, Sanchary Roy, Mihael Vucur, Jennis Kandler, Linda Hammerich, Raphael Mohr, Frank Tacke, Tom F. Ulmer, Ulf P. Neumann, Tom Luedde, Christoph Roderburg, Matias A. Avila. Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC. PLOS ONE 2021; 16(3) doi: 10.1371/journal.pone.0247917
|
| 175 |
Qiang Fang, Yali Zhu, Ying Liang, Huiming Li, Shaoying Yan. Evaluating the diagnostic efficacy of a 4-marker serum panel for hepatitis B virus–related hepatocellular carcinoma. Laboratory Medicine 2026; 57(3) doi: 10.1093/labmed/lmaf093
|
| 176 |
Shanshan Jiang, Yuyang Wang, Xiaona Fu, Jie Lou, Bingxin Gong, Weiwei Liu, Yi Li, Yuxin Sun, Chunfeng Liu, Zifang Song, Guofeng Zhou. Clinical significance of AFP and PIVKA-II for predicting prognosis in hepatocellular carcinoma patients treated with immune checkpoint inhibitors. Therapeutic Advances in Medical Oncology 2025; 17 doi: 10.1177/17588359251386801
|
| 177 |
Takako Inoue, Yasuhito Tanaka. Comprehensive Guide to Hepatitis Advances. 2023; doi: 10.1016/B978-0-323-98368-6.00009-4
|
| 178 |
Fatah Ben Moussa. Molecularly imprinted polymers meet electrochemical cancer chemosensors: A critical review from a clinical and economic perspective. Microchemical Journal 2023; 191 doi: 10.1016/j.microc.2023.108838
|
| 179 |
Hebatalla Said Ali, Mariam Sameh Boshra, Mahmoud Shawky El Meteini, Ayman El-Sayed Shafei, Marwa Matboli. lncRNA- RP11-156p1.3, novel diagnostic and therapeutic targeting via CRISPR/Cas9 editing in hepatocellular carcinoma. Genomics 2020; 112(5) doi: 10.1016/j.ygeno.2020.06.020
|
| 180 |
Hong Kiat Lim, Gary P. Jeffrey, Grant A. Ramm, Carolina Soekmadji. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.587628
|
| 181 |
Joshua Hawley, Yongqing Tang, Anders Sjöström, Adolfo Fuentes-Alburo, François Tranquart. The Clinical Utility of Liver-Specific Ultrasound Contrast Agents During Hepatocellular Carcinoma Imaging. Ultrasound in Medicine & Biology 2025; 51(3) doi: 10.1016/j.ultrasmedbio.2024.10.011
|
| 182 |
Li‐Jun Chang, Ming‐Chin Yu, Wei‐Chen Lee, Fu‐Chun Chan, Ying‐Jun Pan, Dar‐In Tai, Wen‐Hui Su. Assessment of Circulating Tumor DNA for Early Detection of Hepatocellular Carcinoma in Alpha‐Fetoprotein–Negative Patients With Cirrhotic Nodules. JGH Open 2026; 10(1) doi: 10.1002/jgh3.70331
|
| 183 |
Lei Wang, Jianjiang Pan, Bita Badehnoosh. Electrochemical biosensors for hepatocellular carcinoma. Clinica Chimica Acta 2025; 574 doi: 10.1016/j.cca.2025.120328
|
| 184 |
Giuseppa Augello, Alessandra Cusimano, Melchiorre Cervello, Antonella Cusimano. Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview. Cancers 2024; 16(7) doi: 10.3390/cancers16071415
|
| 185 |
Xin-Ming Zhao, Zhong-Wei Chen, Long-Bin Hu, Yong-Tao Mi, Deng-Feng Li, Zhi-Yuan Wu, Kun Chen, Si-Yun Liu, Shuang Wang, Xiao-Hong Ma. Development and <i>in vitro</i> study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(24): 3030-3043 doi: 10.3748/wjg.v25.i24.3030
|
| 186 |
Fanghua Chen, Junming Wang, Yingcheng Wu, Qiang Gao, Shu Zhang. Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.822449
|
| 187 |
Jia-Cheng Tang, Yi-Li Feng, Tao Guo, An-Yong Xie, Xiu-Jun Cai. Circulating tumor DNA in hepatocellular carcinoma: trends and challenges. Cell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0100-z
|
| 188 |
Abdelrhman Elkhouly, Ahmed Alksas, Gehad A. Saleh, Mohamed Shehata, Abdelrahman Karawia, Mohammed Ghazal, Sohail Contractor, Ayman El-Baz. Pattern Recognition. Lecture Notes in Computer Science 2025; 15327 doi: 10.1007/978-3-031-78398-2_26
|
| 189 |
Ying Kong, Hao Chen, Mengyu Chen, Yongshuai Li, Jiarong Li, Qi Liu, Huan Xiong, Tangxi Guo, Yan Xie, Yufeng Yuan, Xiao-Lian Zhang. Abnormal ECA-Binding Membrane Glycans and Galactosylated CAT and P4HB in Lesion Tissues as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.855952
|
| 190 |
Qingmei Deng, Xinhui Zhang, Xiaofeng Wan, Xin Zheng, Hongzhi Wang, Jingyu Zhao, Hong-Qiang Wang, Wulin Yang. The chemokine CCL20 can assist AFP in serological diagnosis of hepatocellular carcinoma. Heliyon 2024; 10(5) doi: 10.1016/j.heliyon.2024.e26774
|
| 191 |
WEN-ZHOU DING, QING-FENG NI, YE-TING LU, LIANG-LIANG KONG, JIAN-JUN YU, LONG-WEI TAN, LIAN-BAO KONG. MicroRNA-497 regulates cell proliferation in hepatocellular carcinoma. Oncology Letters 2016; 11(2) doi: 10.3892/ol.2015.3981
|
| 192 |
Hongwei Wu, Lijing Fan, Haiping Liu, Baozhang Guan, Bo Hu, Fanna Liu, Berthold Hocher, Lianghong Yin, Brandi L. Cantarel. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/4030915
|
| 193 |
Emma Reungoat, Boyan Grigorov, Fabien Zoulim, Eve-Isabelle Pécheur. Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis. Cancers 2021; 13(9) doi: 10.3390/cancers13092270
|
| 194 |
Jian Li, Tiezheng Wang, Boxun Jin, Wenlei Li, Zhenshun Wang, Haitao Zhang, Yunjun Song, Ning Li. Diagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma: a systematic review with meta-analysis. The International Journal of Biological Markers 2018; 33(4) doi: 10.1177/1724600818784409
|
| 195 |
Bin Sun, Weidan Ji, Chunying Liu, Xuejing Lin, Lei Chen, Haihua Qian, Changqing Su. miR‐2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting JAG2. Liver International 2022; 42(7) doi: 10.1111/liv.15284
|
| 196 |
Alyson P Black, Anand S Mehta. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome. Current Opinion in Pharmacology 2018; 41 doi: 10.1016/j.coph.2018.04.002
|
| 197 |
Xin-Fei Xu, Lei Liang, Hao Xing, Feng Shen, Dong-Sheng Huang, Wan Y Lau, Tian Yang. Clinical Utility of Serum Biomarkers for Hepatocellular Carcinoma. Biomarkers in Medicine 2021; 15(3) doi: 10.2217/bmm-2020-0474
|
| 198 |
Antonio Lacalamita, Grazia Serino, Ester Pantaleo, Alfonso Monaco, Nicola Amoroso, Loredana Bellantuono, Emanuele Piccinno, Viviana Scalavino, Francesco Dituri, Sabina Tangaro, Roberto Bellotti, Gianluigi Giannelli. Artificial Intelligence and Complex Network Approaches Reveal Potential Gene Biomarkers for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(20) doi: 10.3390/ijms242015286
|
| 199 |
Manyu Li, Jing Sun, Yan Wang, Jun Ma, Xiaotian Hao, Yan Liu, Cheng Zhou, Haiwei Zhou. Construction of a hepatocellular carcinoma high-risk population rating scale and independent predictors' assessment. The American Journal of the Medical Sciences 2024; 367(3) doi: 10.1016/j.amjms.2023.11.016
|
| 200 |
Lin Xiang, La-Mei Chen, Yu-Jia Zhai, Wei-Juan Sun, Jie-Ru Yang, Yu-Chen Fan, Kai Wang. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma. Life Sciences 2021; 270 doi: 10.1016/j.lfs.2021.119061
|
| 201 |
Chenjun Huang, Xiao Xiao, Lin Tong, Zhiyuan Gao, Jun Ji, Lin Zhou, Ya Li, Lijuan Liu, Huijuan Feng, Meng Fang, Chunfang Gao. Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers. Journal of Hepatocellular Carcinoma 2024; doi: 10.2147/JHC.S447700
|
| 202 |
Guanlin Zhou, Yijun Zeng, Yingmin Luo, Sheng Guo, Longyuan Bao, Qiong Zhang. Urine miR-93-5p is a promising biomarker for early detection of HBV-related hepatocellular carcinoma. European Journal of Surgical Oncology 2022; 48(1) doi: 10.1016/j.ejso.2021.06.015
|
| 203 |
Jihan Wang, Yangyang Wang, Jing Xu, Qiying Song, Jingbo Shangguan, Mengju Xue, Hanghui Wang, Jingyi Gan, Wenjie Gao. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma. Science Progress 2021; 104(3) doi: 10.1177/00368504211029429
|
| 204 |
Xiaojing Ren, Yuanyuan Ji, Xuhua Jiang, Xun Qi. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20181423
|
| 205 |
John-Alexander Preuß, Peggy Reich, Nicole Bahner, Janina Bahnemann. Aptamers in Biotechnology. Advances in Biochemical Engineering/Biotechnology 2020; 174 doi: 10.1007/10_2020_125
|
| 206 |
Xue-Min Wu, Zhi-Feng Xi, Pinhu Liao, Hong-Dong Huang, Xiao-Ying Huang, Chao Wang, Yun Ma, Qiang Xia, Jin-Guang Yao, Xi-Dai Long. Diagnostic and prognostic potential of serum microRNA-4651 for patients with hepatocellular carcinoma related to aflatoxin B1. Oncotarget 2017; 8(46) doi: 10.18632/oncotarget.16027
|
| 207 |
Yatrasana Singh, Barry Raghunanan, Ravi Maharaj. A Rare Case of Non-cirrhotic Hepatocellular Carcinoma in a Female Adolescent: Diagnostic and Multimodal Treatment Challenges in a Low-Resource Setting. Cureus 2025; doi: 10.7759/cureus.99925
|
| 208 |
Yufei Deng, Bangya Yang, Zelan Yang, Hanyu Xiao, Yan Zou, Cheng Zou, Song Yang, Xi Sun, Yiting Wang, Jin Bai, Liaoqiong Fang, Zhibiao Wang. Engineered E. coli OMVs Carrying the Membrane-Binding hGC33 Fragment Precisely Target Liver Cancer and Effectively Treat Tumor. International Journal of Nanomedicine 2025; doi: 10.2147/IJN.S513508
|
| 209 |
Xiao-Ying Huang, Chun-Ying Luo, Xue-Ming Wu, Jin-Guang Yao, Chao Wang, Bing-Chen Huang, Jun Lu, Xing-Zhizi Wang, Tian-Qi Zhang, Qiang Xia, Xi-Dai Long. Aflatoxin-Control, Analysis, Detection and Health Risks. 2017; doi: 10.5772/intechopen.68419
|
| 210 |
Nina Hauptman, Jože Pižem, Daša Jevšinek Skok. AmiCa: Atlas of miRNA-gene correlations in cancer. Computational and Structural Biotechnology Journal 2024; 23 doi: 10.1016/j.csbj.2024.05.030
|
| 211 |
Shouzhang Yang, Huajie Cai, Bingren Hu, Jinfu Tu. LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values. Bioscience Reports 2019; 39(7) doi: 10.1042/BSR20190615
|
| 212 |
Jing Zhen, Jingying Pan, Xuanrui Zhou, Zichuan Yu, Yike Jiang, Yiyang Gong, Yongqi Ding, Yue Liu, Liangyun Guo. FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma. Aging 2023; doi: 10.18632/aging.204619
|
| 213 |
S. S. Sleptsova, S. I. Malov, S. S. Sleptsov, P. V. Nikiforov, M. S. Gumennikova, E. I. Panferova, I. V. Malov. Effectiveness of an interdisciplinary approach to early diagnosis of hepatocellular carcinoma. Yakut Medical Journal 2025; (4) doi: 10.25789/YMJ.2025.92.17
|
| 214 |
Arooj Fatima, Jarutas Andritsch. Machine Learning Model for Predicting Hepatocellular Carcinoma in Hepatitis C Patients. 2024 2nd International Conference on Computing and Data Analytics (ICCDA) 2024; doi: 10.1109/ICCDA64887.2024.10867403
|
| 215 |
Sinem Nalbantoglu, Abdullah Karadag. Metabolomics bridging proteomics along metabolites/oncometabolites and protein modifications: Paving the way toward integrative multiomics. Journal of Pharmaceutical and Biomedical Analysis 2021; 199 doi: 10.1016/j.jpba.2021.114031
|
| 216 |
Shuji Akimoto, Hiroyuki Tahara, Senichiro Yanagawa, Kentaro Ide, Yuka Tanaka, Tsuyoshi Kobayashi, Hideki Ohdan. Heterophile carbohydrate antigen N‐glycolylneuraminic acid as a potential biomarker in patients with hepatocellular carcinoma. Cancer Reports 2023; 6(8) doi: 10.1002/cnr2.1831
|
| 217 |
Yaohui Sun, Zhiming Gan, Xiaojin Wang, Jian Liu, Wei Zhong, Zhiyan Zhang, Jiebin Zuo, Hang Zhong, Xiuting Huang, Zhixiang Yan, Qingdong Cao. Integrative metagenomic, transcriptomic, and proteomic analysis reveal the microbiota-host interplay in early-stage lung adenocarcinoma among non-smokers. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05485-0
|
| 218 |
Miner Hu, Xiaojun Xia, Lichao Chen, Yunpeng Jin, Zhenhua Hu, Shudong Xia, Xudong Yao. Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma. Annals of Hepatology 2023; 28(6) doi: 10.1016/j.aohep.2023.101137
|
| 219 |
Hongxi Ma, Chunchun Huang, Qiuhuan Huang, Guangzhi Li, Jun Li, Bin Huang, Qiuhong Zhong, Cong Cao. Circular RNA circ_0014717 Suppresses Hepatocellular Carcinoma Tumorigenesis Through Regulating miR-668-3p/BTG2 Axis. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.592884
|
| 220 |
Nicole Golob-Schwarzl, Sonja Kessler, Johannes Haybaeck. Mechanisms of Molecular Carcinogenesis – Volume 2. 2017; doi: 10.1007/978-3-319-53661-3_6
|
| 221 |
Yingming Zhang, Yanfei Liu, Yuchong Wei, Ze Ren, Ying-Hua Jin, Guiying Li. The role of rare ginsenosides in the prevention and treatment of liver diseases. Journal of Ethnopharmacology 2026; 355 doi: 10.1016/j.jep.2025.120666
|
| 222 |
Hasan Çağrı Yıldırım, Gozde Kavgaci, Elvin Chalabiyev, Omer Dizdar. Advances in the Early Detection of Hepatobiliary Cancers. Cancers 2023; 15(15) doi: 10.3390/cancers15153880
|
| 223 |
Selin Oncul, Gulsah Karakaya, Mutlu Dilsiz Aytemir, Ayse Ercan. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance. Chemical Biology & Drug Design 2019; 94(6) doi: 10.1111/cbdd.13615
|
| 224 |
Shan Lu, Xinkui Liu, Chao Wu, Jingyuan Zhang, Antony Stalin, Zhihong Huang, Yingying Tan, Zhishan Wu, Leiming You, Peizhi Ye, Changgeng Fu, Xiaomeng Zhang, Jiarui Wu. Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis. Medicine 2023; 102(29) doi: 10.1097/MD.0000000000033990
|
| 225 |
Manuela Cabiati, Melania Gaggini, Paolo De Simone, Silvia Del Ry. Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression. Clinical & Experimental Metastasis 2022; 39(4) doi: 10.1007/s10585-022-10164-9
|
| 226 |
Haidong Zhang, Xuanlong Du, Hui Dong, Wenjing Xu, Pengcheng Zhou, Shiwei Liu, Xin Qing, Yu Zhang, Meng Yang, Yewei Zhang. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02424-5
|
| 227 |
Lei Yao, Jun Li, Bo Jiang, Zeyu Zhang, Xinying Li, Xiwu Ouyang, Yao Xiao, Guodong Liu, Zhiming Wang, Gewen Zhang. RNF2 inhibits E-Cadherin transcription to promote hepatocellular carcinoma metastasis via inducing histone mono-ubiquitination. Cell Death & Disease 2023; 14(4) doi: 10.1038/s41419-023-05785-1
|
| 228 |
Jun-feng Sun. Roles of Circular RNAs And Their Interactions With MicroRNAs in Human Disorders. Clinical surgery research communications 2018; 2(2) doi: 10.31491/CSRC.2018.6.012
|
| 229 |
Heng Liang Tan, Andre Choo. Opportunities for Antibody Discovery Using Human Pluripotent Stem Cells: Conservation of Oncofetal Targets. International Journal of Molecular Sciences 2019; 20(22) doi: 10.3390/ijms20225752
|
| 230 |
Jiyun Zhang, Zhizhen Lai, Rui Ding, Jinyu zhou, Zhonghao Yuan, Dan Li, Xuzhen Qin, Jiang Zhou, Zhili li. Diagnostic potential of site-specific serotransferrin N-glycosylation in discriminating different liver diseases. Clinica Chimica Acta 2023; 539 doi: 10.1016/j.cca.2022.12.015
|
| 231 |
Hitoshi Yoshiji, Takemi Akahane, Kei Moriya, Hideto Kawaratani, Shinya Sato, Soichiro Saikawa, Yasuhiko Sawada, Yukihisa Fujinaga, Ryuichi Noguchi, Keisuke Nakanishi, Yuki Tsuji, Kosuke Kaji, Naotaka Shimozato, Mitsuteru Kitade, Tadashi Namisaki, Hiroaki Takaya. Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients. World Journal of Gastrointestinal Oncology 2019; 11(10): 887-897 doi: 10.4251/wjgo.v11.i10.887
|
| 232 |
Chuanwen Yu, Chuang Sun, Shangxiang Chen. Diagnostic Value of Multislice Spiral Computed Tomography Combined with Serum AFP, TSGF, and GP73 Assay in the Diagnosis of Primary Liver Cancer. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/6581127
|
| 233 |
Abdel Hady A. Abdel Wahab, Medhat S. El-Halawany, Ahmad A. Emam, Ammar Elfiky, Zakaria Y. Abd Elmageed. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus. Biomarkers 2017; 22(7) doi: 10.1080/1354750X.2016.1252966
|
| 234 |
Mengtao Xing, Xinzhi Wang, Robert Kirken, Ling He, Jian-Ying Zhang. Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment. International Journal of Molecular Sciences 2021; 22(11) doi: 10.3390/ijms22116139
|
| 235 |
Chang‐Hai Liu, Antonio Gil‐Gómez, Javier Ampuero, Manuel Romero‐Gómez. Diagnostic accuracy of SCCA and SCCA‐IgM for hepatocellular carcinoma: A meta‐analysis. Liver International 2018; 38(10) doi: 10.1111/liv.13867
|
| 236 |
Shuai Chen, Liming Tang, Adrien Guillot, Hanyang Liu. Bariatric Surgery Associates with Nonalcoholic Steatohepatitis/Hepatocellular Carcinoma Amelioration via SPP1 Suppression. Metabolites 2022; 13(1) doi: 10.3390/metabo13010011
|
| 237 |
Philip M. Hemken, Lori J. Sokoll, Xiaoqing Yang, Jianliang Dai, Debra Elliott, Susan H. Gawel, Michael Lucht, Ziding Feng, Jorge A. Marrero, Sudhir Srivastava, Daniel W. Chan, Gerard J. Davis. Validation of a novel model for the early detection of hepatocellular carcinoma. Clinical Proteomics 2019; 16(1) doi: 10.1186/s12014-018-9222-0
|
| 238 |
Bhavya Banjan, Riya Vishwakarma, Krishnapriya Ramakrishnan, Radul R. Dev, Haritha Kalath, Pankaj Kumar, Sowmya Soman, Rajesh Raju, Amjesh Revikumar, Niyas Rehman, Chandran S. Abhinand. Targeting AFP-RARβ complex formation: a potential strategy for treating AFP-positive hepatocellular carcinoma. Molecular Diversity 2025; 29(2) doi: 10.1007/s11030-024-10915-8
|
| 239 |
Manuela Cabiati, Nicoletta Di Giorgi, Costanza Salvadori, Francesco Finamore, Serena Del Turco, Antonella Cecchettini, Silvia Rocchiccioli, Silvia Del Ry. Transcriptional level evaluation of osteopontin/miRNA-181a axis in hepatocellular carcinoma cell line-secreted extracellular vesicles. Pathology - Research and Practice 2022; 238 doi: 10.1016/j.prp.2022.154088
|
| 240 |
Rui Sun, Xiaoru Wang, Jiayi Ma, Yuying Cai, Lei Li, Shanshan Wang. The Roles and Clinical Significance of Major Hepatic‐Derived Metabolites in Hepatocellular Carcinoma. Journal of Gastroenterology and Hepatology 2025; 40(10) doi: 10.1111/jgh.70008
|
| 241 |
Jung Woo Eun, Jeong Won Jang, Hee Doo Yang, Jooyoung Kim, Sang Yean Kim, Min Jeong Na, Eunbi Shin, Jin Woong Ha, Soyoung Jeon, Young Min Ahn, Won Sang Park, Suk Woo Nam. Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma. Journal of Clinical Medicine 2022; 11(8) doi: 10.3390/jcm11082128
|
| 242 |
Daniel F Lyman, Amanda Bell, Alyson Black, Hayley Dingerdissen, Edmund Cauley, Nikhita Gogate, David Liu, Ashia Joseph, Robel Kahsay, Daniel J Crichton, Anand Mehta, Raja Mazumder. Modeling and integration of N-glycan biomarkers in a comprehensive biomarker data model. Glycobiology 2022; doi: 10.1093/glycob/cwac046
|
| 243 |
Zhenjie Li, Lisha Mou, Haibin Gao, Yi Zeng, Xueyi Tang, Xuesong Deng, Zuhui Pu, Yong Ni, Yongqiang Zhan. Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma. Medicine 2019; 98(32) doi: 10.1097/MD.0000000000016725
|
| 244 |
Dalia H. Abou-Elela, Eman Abdel Sameea, Tamer Fakhry. Assessment of the diagnostic role of annexin A2 (ANXA2) and insulin-like growth factor-1 as serum markers for hepatocellular carcinoma. Egyptian Liver Journal 2016; 6(1) doi: 10.1097/01.ELX.0000481901.80695.e7
|
| 245 |
Xiaojun Luo, Yang Wang, Xi Zhang, Wenbin Liu, Zhongjie Shi. The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma. Journal of Oncology 2022; 2022 doi: 10.1155/2022/5735462
|
| 246 |
Anping Song, Tingting Ding, Na Wei, Jieren Yang, Mingyue Ma, Shuguo Zheng, Huanhuan Jin. Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity. Toxicology and Applied Pharmacology 2023; 472 doi: 10.1016/j.taap.2023.116574
|
| 247 |
Xinying Chang, Cong Han, Haishuo Ji, Zhe Zeng, Jingyi Yang, Qirui Liu, Chao Jia, Lili Zhao, Chunlei Zhou, Shujia Chen, Wolfgang Knoll, Jia Li, Zhenglu Wang, Liyun Zhang. SPARC: A programmable molecular diagnostic platform based on a signal-triggered, self-supplied crRNA and tiered PER-transcription-CRISPR cascade for early detection of hepatocellular carcinoma. Analytica Chimica Acta 2026; 1394 doi: 10.1016/j.aca.2026.345209
|
| 248 |
Dongxu Zhao, Jian Cao, Lei Zhang, Shaohua Zhang, Song Wu. Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment. Biosensors 2022; 12(5) doi: 10.3390/bios12050342
|
| 249 |
Jun Ho Lee, Jae Hee Suh, Soo Youn Choi, Hyun Je Kang, Hwan Hee Lee, Byeong Jin Ye, Gap Ryol Lee, Seok Won Jung, Chang Jae Kim, Whaseon Lee-Kwon, Jiyoung Park, Kyungjae Myung, Neung Hwa Park, Hyug Moo Kwon. Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis. Gut 2019; 68(2) doi: 10.1136/gutjnl-2017-315348
|
| 250 |
Chao Han, Lanzhu Gao, Han Bai, Xiaoguang Dou. Identification of a role for serum aldo‑keto reductase family 1 member B10 in early detection of hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9547
|
| 251 |
Changzheng Li, Jie Chen, Yishan Li, Binghuo Wu, Zhitao Ye, Xiaobin Tian, Yan Wei, Zechen Hao, Yuan Pan, Hongli Zhou, Keyue Yang, Zhiqiang Fu, Jingbo Xu, Yanan Lu. 6-Phosphogluconolactonase Promotes Hepatocellular Carcinogenesis by Activating Pentose Phosphate Pathway. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.753196
|
| 252 |
Abdulrahman Al-Shami, Rami Joseph Oweis, Mohamed Ghazi Al-Fandi. Developing an electrochemical immunosensor for early diagnosis of hepatocellular carcinoma. Sensor Review 2021; 41(2) doi: 10.1108/SR-02-2020-0030
|
| 253 |
Overview of Optical Fiber Biosensors for the Detection of Cancer Biomarkers in the Past Decade. ACS Omega 2026; 11(14) doi: 10.1021/acsomega.6c00722
|
| 254 |
Xiumei Wang, Weiwei Zhang, Youde Liu, Wenjing Gong, Ping Sun, Xiangshuo Kong, Miaomiao Yang, Zhihua Wang. Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0153-6
|
| 255 |
Rei Okada, Yuichiro Otsuka, Yoji Kajiwara, Tetsuya Maeda, Jun Ishii, Kazutaka Kimura, Yu Matsumoto, Yuko Ito, Kimihiko Funahashi, Hideaki Shimada. Prognostic and diagnostic effects of high serum midkine levels in patients with hepatocellular carcinoma. Oncology Letters 2024; 27(6) doi: 10.3892/ol.2024.14416
|
| 256 |
Lorella Maniscalco, Katia Varello, Simona Zoppi, Giuseppina Abbamonte, Marta Ferrero, Elena Torres, Federica Ostorero, Francesca Rossi, Elena Bozzetta. Abnormal Prothrombin (PIVKA-II) Expression in Canine Tissues as an Indicator of Anticoagulant Poisoning. Animals 2021; 11(9) doi: 10.3390/ani11092612
|
| 257 |
Andrew DelaCourt, Alyson Black, Peggi Angel, Richard Drake, Yujin Hoshida, Amit Singal, David Lewin, Bachir Taouli, Sara Lewis, Myron Schwarz, M. Isabel Fiel, Anand S. Mehta. N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes. Molecular Cancer Research 2021; 19(11) doi: 10.1158/1541-7786.MCR-21-0348
|
| 258 |
Xi-wu Zhang, Qiu-han Li, Zuo-di Xu, Jin-jin Dou. STAT1-induced regulation of lncRNA ZFPM2-AS1 predicts poor prognosis and contributes to hepatocellular carcinoma progression via the miR-653/GOLM1 axis. Cell Death & Disease 2021; 12(1) doi: 10.1038/s41419-020-03300-4
|
| 259 |
Jinlin Hou, Thomas Berg, Arndt Vogel, Teerha Piratvisuth, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Katarina Malinowsky, Peter Findeisen, Johannes Kolja Hegel, Wenzel Schöning, Kairat Madin, Konstantin Kroeniger, Henry Lik-Yuen Chan, Ashish Sharma. Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies. JHEP Reports 2025; 7(2) doi: 10.1016/j.jhepr.2024.101263
|
| 260 |
Yanlin Jin, Yi Zhang, Xiaoming Luo. circRNA_PTPRA functions as a sponge of miR‑582‑3p to regulate hepatocellular carcinoma cell proliferation, migration, invasion and apoptosis. Experimental and Therapeutic Medicine 2021; 22(5) doi: 10.3892/etm.2021.10711
|
| 261 |
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology 2020; 26(3) doi: 10.3350/cmh.2020.0032
|
| 262 |
Xiaoting Song, Ailu Wu, Zhixiao Ding, Shixiong Liang, Chunyan Zhang. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection. Cancer Research and Treatment 2020; 52(3) doi: 10.4143/crt.2019.749
|
| 263 |
Xiao Wang, Ran Sun, Na Che, Danfang Zhang, Yanlei Li, Nan Zhao. Overexpression of NDRG1 leads to poor prognosis in hepatocellular carcinoma through mediating immune infiltration and EMT. Digestive and Liver Disease 2024; 56(8) doi: 10.1016/j.dld.2024.01.182
|
| 264 |
Jelena Jakab, Anita Matić, Matea Matić Ličanin, Dunja Igrec, Jelena Šakić Radetić, Nikola Volarić, Aleksandar Včev. Biomarkers in Cancer Detection - From Screening to Improving Treatment Outcomes [Working Title]. 2026; doi: 10.5772/intechopen.1014044
|
| 265 |
Jinping Li, Sheng Zhao, Zaisheng Ling, Daqing Li, Guangsheng Jia, Chenglei Zhao, Xue Lin, Yanmei Dai, Huijie Jiang, Song Wang, Yuvaraja Teekaraman. Dual‐Energy Computed Tomography Imaging in Early‐Stage Hepatocellular Carcinoma: A Preliminary Study. Contrast Media & Molecular Imaging 2022; 2022(1) doi: 10.1155/2022/2146343
|
| 266 |
Akiko Eguchi, Motoh Iwasa, Yasuyuki Tamai, Minori Yamada, Koji Okuno, Ryuta Shigefuku, Kyoko Yoshikawa, Mina Tempaku, Koji Sakaguchi, Hideaki Tanaka, Kazushi Sugimoto, Yoshinao Kobayashi, Tetsuji Yamaguchi, Hayato Nakagawa. The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.993705
|
| 267 |
Mingshuang Lai, Deyuan Li, Meiliang Liu, Ruirui Zhang, Lijun Wang, Wenyi Peng, Haotian Xu, Siqian Wu, Si Liang, Ye Gu, Aruo Nan, Xiaoyun Zeng. CircFAM114A2 inhibits the progression of hepatocellular carcinoma via miR‐630/HHIP axis. Cancer Medicine 2023; 12(11) doi: 10.1002/cam4.5894
|
| 268 |
Mi Zhang, Wei Zhao, Shanshan Liu, Haichuan Liu, Liang Liu, Qiling Peng, Chengyou Du, Ning Jiang. H/ACA snoRNP Gene Family as Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma. Pharmacogenomics and Personalized Medicine 2021; doi: 10.2147/PGPM.S333838
|
| 269 |
Rana A. Youness, Hossam A. Hassan, Tasneem Abaza, Ahmed A. Hady, Hekmat M. El Magdoub, Mohamed Ali, Johannes Vogel, Markus Thiersch, Max Gassmann, Nadia M. Hamdy, Mostafa A. Aboouf. A Comprehensive Insight and In Silico Analysis of CircRNAs in Hepatocellular Carcinoma: A Step toward ncRNA-Based Precision Medicine. Cells 2024; 13(15) doi: 10.3390/cells13151245
|
| 270 |
Ayman F. El-Shayeb, Nihal M. El-Habachi, Amal R. Mansour, Mariam S. Zaghloul. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients. Medicine 2021; 100(17) doi: 10.1097/MD.0000000000025112
|
| 271 |
Connor A. West, Alyson P. Black, Anand S. Mehta. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; doi: 10.1007/978-3-030-21540-8_5
|
| 272 |
Duong Quang Huy, Nguyen Xuan Khai, Tran Hong Thinh, Bui Thuy Linh, Nghiem Ngoc Minh, Vo Thi Bich Thuy. Application of Indirect ELISA and PCR Techniques for Detecting of Hepatocellular Carcinoma using Des-gamma Carboxyprothrombin, Alpha-fetoprotein, and Thioredoxin Biomarkers. Molecular Biotechnology 2026; 68(2) doi: 10.1007/s12033-025-01401-z
|
| 273 |
Yingshi Zhang, Jiayue Gao, Yu Bao, Yang Liu, Yimeng Tong, Shuqing Jin, Qingchun Zhao. Diagnostic accuracy and prognostic significance of osteopontin in liver cirrhosis and hepatocellular carcinoma: a Meta-analysis. Biomarkers 2022; 27(1) doi: 10.1080/1354750X.2021.2008009
|
| 274 |
Fengjie Wan, Yujia Zhu, Feixiang Wu, Xuejing Huang, Ying Chen, Yi Zhou, Hongtao Li, Lifang Liang, Lirong Qin, Qi Wang, Min He. Retinol-binding protein 4 as a promising serum biomarker for the diagnosis and prognosis of hepatocellular Carcinoma. Translational Oncology 2024; 45 doi: 10.1016/j.tranon.2024.101979
|
| 275 |
James Yu, Robin Park, Richard Kim. Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S341195
|
| 276 |
Yongchang Zheng, Qianqian Huang, Zijian Ding, Tingting Liu, Chenghai Xue, Xinting Sang, Jin Gu. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma. Briefings in Bioinformatics 2016; doi: 10.1093/bib/bbw094
|
| 277 |
Yu Wang, Bin-hui Xie, Wei-hao Lin, Yong-hui Huang, Jia-yan Ni, Jie Hu, Wei Cui, Jun Zhou, Long Shen, Lin-feng Xu, Fan Lian, He-ping Li. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2. Oncogene 2019; 38(25) doi: 10.1038/s41388-019-0766-x
|
| 278 |
Ayman Menessy, Ehab Fouda, Salah Aref, Ramy Agwa. The Value of Serum MidKine as a Marker of Hepatocellular Carcinoma on Top of Hepatitis C Virus Related Cirrhosis. Journal of Biosciences and Medicines 2022; 10(04) doi: 10.4236/jbm.2022.104005
|
| 279 |
Raghda Saad Zaghloul Taleb, Ahmed Elsayed Zeid, Maha Ahmed Nabil, Pacint Elsayed Moez. Plasma Long Non-Coding RNA ZFAS1 as a Potential Diagnostic Biomarker for HCV-Related Hepatocellular Carcinoma. Molecular Genetics, Microbiology and Virology 2022; 37(4) doi: 10.3103/S0891416822040061
|
| 280 |
Jiaheng Zhu, Shaowei Lin, Baichang Deng, Jiaqing Shen, Lihuang Zeng, Qiang Niu, Tianhao Huang, Xinyue Huang, Mengqi Jiang, Wei Chen, Yinong Xie, Annuo Chen, Youyu Zhang, Yahong Chen, Qiwei Guo, Boan Li, Jinfeng Zhu. A meta-plasmonic biosensor for minimal protein interference profiling of serum extracellular vesicles enables high-specific discrimination of liver cancer subtypes. Chemical Engineering Journal 2026; 527 doi: 10.1016/j.cej.2025.172071
|
| 281 |
Qian-Hui Xu, Qing Yuan, Yu-Qing Zhang, Biao Li, You-Lan Min, Qian-Min Ge, Rong-Bin Liang, Yi Shao. Ocular Metastasis in Elderly Male Bladder Cancer Patients: Potential Risk Factors. American Journal of Men's Health 2020; 14(2) doi: 10.1177/1557988320908998
|
| 282 |
Longqiu Yang, Pengcheng Luo, Qiong Song, Xuejie Fei. DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation. Biomedicine & Pharmacotherapy 2018; 99 doi: 10.1016/j.biopha.2018.01.161
|
| 283 |
Wenbiao Chen, Minglin Ou, Donge Tang, Yong Dai, Weibo Du, Eirini Rigopoulou. Identification and Validation of Immune‐Related Gene Prognostic Signature for Hepatocellular Carcinoma. Journal of Immunology Research 2020; 2020(1) doi: 10.1155/2020/5494858
|
| 284 |
Moustafa A. Sakr, Mahmood A. Al-Azzawi, Anis Anis, Amal A. Abd El-Aziz, Mohamed E. Ebeid, Mahmoud A. Shokeer, Aysam fayed. The correlation between P53 and COX-2 expression and the pathological alteration in hepatocellular carcinoma. Egyptian Journal of Medical Human Genetics 2022; 23(1) doi: 10.1186/s43042-022-00230-y
|
| 285 |
Tian Yang, Hao Xing, Guoqiang Wang, Nianyue Wang, Miaoxia Liu, Cunling Yan, Huijun Li, Lianhua Wei, Shunjun Li, Zhuping Fan, Ming Shi, Wei Chen, Shangli Cai, Timothy M Pawlik, Andrew Soh, Agim Beshiri, Wan Yee Lau, Mengchao Wu, Yijie Zheng, Feng Shen. A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B. Clinical Chemistry 2019; 65(12) doi: 10.1373/clinchem.2019.308965
|
| 286 |
Besnik Muqaku, Martin Eisinger, Samuel M. Meier, Ammar Tahir, Tobias Pukrop, Sebastian Haferkamp, Astrid Slany, Albrecht Reichle, Christopher Gerner. Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma. Molecular & Cellular Proteomics 2017; 16(1) doi: 10.1074/mcp.M116.063313
|
| 287 |
Mo Cheng, Xiufeng Zheng, Jing Wei, Ming Liu. Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review). Experimental and Therapeutic Medicine 2023; 26(6) doi: 10.3892/etm.2023.12285
|
| 288 |
Christiana Christou, Andreas Stylianou, Vasiliki Gkretsi. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker. Cells 2024; 13(2) doi: 10.3390/cells13020136
|
| 289 |
Zifei Wang, Yu Zhong, Zefan Zhang, Kaiqian Zhou, Zhihao Huang, Hao Yu, Longqi Liu, Shiping Liu, Huanming Yang, Jian Zhou, Jia Fan, Liang Wu, Yunfan Sun. Characteristics and Clinical Significance of T-Cell Receptor Repertoire in Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.847263
|
| 290 |
Mingfang Ji, Zhiwei Liu, Ellen T. Chang, Xia Yu, Biaohua Wu, Li Deng, Qianjin Feng, Kuangrong Wei, Xuejun Liang, Shifeng Lian, Wen Quan, Panpan Wang, Yun Du, Zhiheng Liang, Shenglin Xia, Hai Lin, Fugui Li, Weimin Cheng, Weiqiang Chen, Yong Yuan, Weimin Ye. Mass screening for liver cancer: results from a demonstration screening project in Zhongshan City, China. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31119-9
|
| 291 |
Hwajeong Lee, Stephen M Lagana, Tony El Jabbour. Update on hepatocellular carcinoma: Pathologists’ review. World Journal of Gastroenterology 2019; 25(14): 1653-1665 doi: 10.3748/wjg.v25.i14.1653
|
| 292 |
Yanqiu Wang, Tong Wang, Yi Cao, Xu Qiao, Xianhua Han, Zhi-Ping Liu. TopMarker: Computational screening biomarkers of hepatocellular carcinoma from transcriptome and interactome based on differential network topological parameters. Computational Biology and Chemistry 2024; 112 doi: 10.1016/j.compbiolchem.2024.108166
|
| 293 |
Shu An, Xiaoxia Zhan, Min Liu, Laisheng Li, Jian Wu. Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers. Diagnostics 2023; 13(8) doi: 10.3390/diagnostics13081442
|
| 294 |
Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis. BioMed Research International 2018; 2018 doi: 10.1155/2018/5484976
|
| 295 |
Ting Wang, Kun-He Zhang, Piao-Ping Hu, Qin-Si Wan, Fang-Li Han, Jian-Ming Zhou, De-Qiang Huang, Nong-Hua Lv. Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases. Oncotarget 2017; 8(58) doi: 10.18632/oncotarget.22050
|
| 296 |
Xinhe Zhang, Lin Guan, Haoyu Tian, Zilu Zeng, Jiayu Chen, Die Huang, Ji Sun, Jiaqi Guo, Huipeng Cui, Yiling Li. Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.686962
|
| 297 |
Manuela Cabiati, Melania Gaggini, Maria Michela Cesare, Chiara Caselli, Paolo De Simone, Franco Filipponi, Giuseppina Basta, Amalia Gastaldelli, Silvia Del Ry. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up. Cytokine 2017; 99 doi: 10.1016/j.cyto.2017.07.004
|
| 298 |
Bashdar Mahmud Hussen, Kasra Honarmand Tamizkar, Hazha Jamal Hidayat, Mohammad Taheri, Soudeh Ghafouri-Fard. The role of circular RNAs in the development of hepatocellular carcinoma. Pathology - Research and Practice 2021; 223 doi: 10.1016/j.prp.2021.153495
|
| 299 |
Yanhong Chen, Jiao Zhang, Jia Liu, Jianguo Wang, Chao Shi, Lu Lu, Xing Cheng, Guoping Niu, Shuangshuang Zhang, Dawei Cui. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients. Journal of Immunology Research 2022; 2022 doi: 10.1155/2022/1817694
|
| 300 |
Juanjun Huang, Xiaoli Chen, Wei Zhu. MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma. Medicine 2021; 100(12) doi: 10.1097/MD.0000000000025234
|
| 301 |
Na Sun, Yi-Te Lee, Ryan Y. Zhang, Rueihung Kao, Pai-Chi Teng, Yingying Yang, Peng Yang, Jasmine J. Wang, Matthew Smalley, Pin-Jung Chen, Minhyung Kim, Shih-Jie Chou, Lirong Bao, Jing Wang, Xinyue Zhang, Dongping Qi, Juvelyn Palomique, Nicolas Nissen, Steven-Huy B. Han, Saeed Sadeghi, Richard S. Finn, Sammy Saab, Ronald W. Busuttil, Daniela Markovic, David Elashoff, Hsiao-hua Yu, Huiying Li, Anthony P. Heaney, Edwin Posadas, Sungyong You, Ju Dong Yang, Renjun Pei, Vatche G. Agopian, Hsian-Rong Tseng, Yazhen Zhu. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-18311-0
|
| 302 |
Lucia Cerrito, Maria Elena Ainora, Carolina Mosoni, Raffaele Borriello, Antonio Gasbarrini, Maria Assunta Zocco. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy. Cancers 2022; 14(19) doi: 10.3390/cancers14194647
|
| 303 |
Po-Shuan Huang, Cheng-Chih Chang, Chia-Siu Wang, Kwang-Huei Lin. Functional roles of non-coding RNAs regulated by thyroid hormones in liver cancer. Biomedical Journal 2021; 44(3) doi: 10.1016/j.bj.2020.08.009
|
| 304 |
Hua-guo Feng, Chuan-xin Wu, Guo-chao Zhong, Jian-ping Gong, Chun-mu Miao, Bin Xiong. Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mTOR signaling via glutamine mediated energy metabolism. Journal of Cancer Research and Clinical Oncology 2023; 149(17) doi: 10.1007/s00432-023-05360-3
|
| 305 |
Chaowen Zheng, Peng Dai, Hui You, Zhaokun Xian, Wenyun Su, Shixiong Wu, Dong Xing, Cuimin Sun. A compact microfluidic laser-induced fluorescence immunoassay system using avalanche photodiode for rapid detection of alpha-fetoprotein. Analytical Sciences 2024; 40(7) doi: 10.1007/s44211-024-00553-3
|
| 306 |
Feng Gong, Zhiyou Tan, Xiaoyun Shan, Yixia Yang, Songbai Tian, Fuxiang Zhou, Xinghu Ji, Zhike He. A Facile Strategy for Multiplex Protein Detection by a Fluorescent Microsphere-Based Digital Immunoassay. Analytical Chemistry 2024; 96(8) doi: 10.1021/acs.analchem.3c05336
|
| 307 |
Francesco Dituri, Gianluigi Gigante, Rosanna Scialpi, Serena Mancarella, Isabel Fabregat, Gianluigi Giannelli. Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma. Cancers 2022; 14(8) doi: 10.3390/cancers14081902
|
| 308 |
Tomonari Shimagaki, Sachiyo Yoshio, Hironari Kawai, Yuzuru Sakamoto, Hiroyoshi Doi, Michitaka Matsuda, Taizo Mori, Yosuke Osawa, Moto Fukai, Takeshi Yoshida, Yunfei Ma, Tomoyuki Akita, Junko Tanaka, Akinobu Taketomi, Rikinari Hanayama, Tomoharu Yoshizumi, Masaki Mori, Tatsuya Kanto. Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52356-6
|
| 309 |
Wen‐Yin Ko, Shin‐Chwen Yeh, Yun‐Chen Hsu, Hsiao‐Wen Chu, Kuan‐Jiuh Lin. A Flexible Broadband Visible Light Plasmon‐Absorber Based on a 2D Monolayer of Au‐Nanoparticle/TiO2‐Nanowire Core–Shell Heterostructures. Advanced Materials Interfaces 2023; 10(35) doi: 10.1002/admi.202300415
|
| 310 |
Xuekai Hu, Jiayun Wei, Pinyan Liu, Qiuxia Zheng, Yue Zhang, Qichen Zhang, Jia Yao, Jingman Ni. Organoid as a promising tool for primary liver cancer research: a comprehensive review. Cell & Bioscience 2024; 14(1) doi: 10.1186/s13578-024-01287-5
|
| 311 |
Yin Gong, Xiangcheng Li, Mingming Wang. Elevated CircYthdc2 expression is correlated with aggressive features and poor progression-free survival in hepatocellular carcinoma. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04231-0
|
| 312 |
Binglin Cheng, Peitao Zhou, Yuhan Chen. Machine-learning algorithms based on personalized pathways for a novel predictive model for the diagnosis of hepatocellular carcinoma. BMC Bioinformatics 2022; 23(1) doi: 10.1186/s12859-022-04805-9
|
| 313 |
Tan Thinh Nguyen, Thanh Dat Nguyen, Phu Qui Le Nguyen, Phuong Thi Bui, Minh Nam Nguyen. Gene expression-based machine learning model for diagnosis, prognosis, and treatment response prediction in hepatocellular carcinoma: a retrospective study. Journal of Yeungnam Medical Science 2026; 43 doi: 10.12701/jyms.2026.43.21
|
| 314 |
AA Mohamed, D Omran, S El-Feky, H Darwish, AEL Kassas, A Farouk, O Ezzat, SM Abdo, FE Zahran, A El-Demery, MM Omran. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index. British Journal of Biomedical Science 2021; 78(1) doi: 10.1080/09674845.2020.1778842
|
| 315 |
Xian Li, Yang Li, Jie Yuan, Weiwei Zhang, Tianxin Xu, Rongrong Jing, Shaoqing Ju. Serum tRF-33-RZYQHQ9M739P0J as a novel biomarker for auxiliary diagnosis and disease course monitoring of hepatocellular carcinoma. Heliyon 2024; 10(9) doi: 10.1016/j.heliyon.2024.e30084
|
| 316 |
Xitian Liang, Bolin Wu, Haitao Shang, Xue Han, Hui Jing, Yixin Sun, Wen Cheng. VTIQ evaluates antitumor effects of NET‑1 siRNA by UTMD in HCC xenograft models. Oncology Letters 2018; doi: 10.3892/ol.2018.8994
|
| 317 |
Kaida Huang, Yubiao Lin, Keyin Wang, Jianfen Shen, Dahai Wei. ARFIP2 Regulates EMT and Autophagy in Hepatocellular Carcinoma in Part Through the PI3K/Akt Signalling Pathway. Journal of Hepatocellular Carcinoma 2022; doi: 10.2147/JHC.S392056
|
| 318 |
Junye Liu, Yan Yu, Heping Zhao, Lei Guo, Wenjuan Yang, Yuzhu Yan, Jing Lv. Latest insights into the epidemiology, characteristics, and therapeutic strategies of chronic hepatitis B patients in indeterminate phase. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-01942-0
|
| 319 |
Anne Hwang, Christopher Shi, Edward Zhu, Farha Naaz, Ping Zhou, Zainab Rasheed, Michelle Liu, Lindsey S. Jung, Bin Duan, Jingsong Li, Kai Jiang, Latha Paka, Satishkumar V. Gadhiya, Dibyendu Dana, Quaisar Ali, Michael A. Yamin, Itzhak D. Goldberg, Prakash Narayan, Mahesh Narayan. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH. PLOS ONE 2018; 13(6) doi: 10.1371/journal.pone.0198937
|
| 320 |
Guitian He, Juntao Ding, Yong’e Zhang, Mengting Cai, Jing Yang, William C. Cho, Yadong Zheng. microRNA-21: a key modulator in oncogenic viral infections. RNA Biology 2021; 18(5) doi: 10.1080/15476286.2021.1880756
|
| 321 |
Lanjing Zhang. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; doi: 10.1007/978-3-319-68082-8_6
|
| 322 |
Shao-hua Chen, Xu Wang. A high preoperative serum IL-25 level is a negative prognosis predictor after liver resection for HBV-HCC. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.858151
|
| 323 |
Qinggong Yuan, Yan Zhang, Junhui Li, Di Zhang, Wenbin Yang. Circ_TEX2 Functions as a Tumor Suppressor in Hepatoma via miR-96-5p/SPRED1 Axis. Molecular Biotechnology 2023; 65(10) doi: 10.1007/s12033-023-00669-3
|
| 324 |
Jiatao Lou, LingFei Zhang, Shaogang Lv, Chenzi Zhang, Shuai Jiang. Biomarkers for Hepatocellular Carcinoma. Biomarkers in Cancer 2017; 9 doi: 10.1177/1179299X16684640
|
| 325 |
Tayyaba Wali, Saima Ejaz, Shan e Zahra, Mian Abdur Rehman Arif, Fatma Hussain, Muhammad Shahid, Muafia Baigum, Atiqa Nudrat, Fariha Naz, Saadiya Zia. miR-195 mimic, a new therapeutic strategy for suppressing CDK6 expression and progression of hepatocellular carcinoma: a pilot study. Arab Journal of Gastroenterology 2026; 27(2) doi: 10.1016/j.ajg.2026.03.003
|
| 326 |
Qingqing Lu, Jie Li, Hui Cao, Chenlu Lv, Xiaolin Wang, Shiqiong Cao. Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis. Bioscience Reports 2020; 40(3) doi: 10.1042/BSR20192424
|
| 327 |
Dejun Li, Shengnan Jia, Shuyue Wang, Lianghai Hu. Glycoproteomic Analysis of Urinary Extracellular Vesicles for Biomarkers of Hepatocellular Carcinoma. Molecules 2023; 28(3) doi: 10.3390/molecules28031293
|
| 328 |
Jacek Baj, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk, Piero Portincasa. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers 2022; 14(6) doi: 10.3390/cancers14061493
|
| 329 |
Rishila Ghosh, Rakin Ahmed, Hafiz Ahmed, Bishnu P. Chatterjee. Phosphorylated Proteins from Serum: A Promising Potential Diagnostic Biomarker of Cancer. International Journal of Molecular Sciences 2022; 23(20) doi: 10.3390/ijms232012359
|
| 330 |
Xiaoyu Sun, Yaoqi Gui, Tai Yang, Lingbing Chen, Yi Zhang, Ling Yan, Weixian Chen, Bo Wang. PD-L1+ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC. Cancer Immunology, Immunotherapy 2024; 73(12) doi: 10.1007/s00262-024-03833-z
|
| 331 |
Marco Cagnin, Alessandra Biasiolo, Andrea Martini, Mariagrazia Ruvoletto, Santina Quarta, Silvano Fasolato, Paolo Angeli, Giorgio Fassina, Patrizia Pontisso. Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56633-2
|
| 332 |
Kwadwo Apeadu Danso, Rosemary Sefakor Akuaku, Rebekah Ruth Taylor, Emmanuella Amoako, Kofi Ulzen‐Appiah, Bashiru Babatunde Jimah, Lily Gloria Tagoe. A case report of a teenager with hepatitis B surface antigen‐positive multifocal hepatocellular carcinoma in a noncirrhotic liver. Clinical Case Reports 2022; 10(3) doi: 10.1002/ccr3.5622
|
| 333 |
Hang Tuo, Yufeng Wang, Liang Wang, Bowen Yao, Qing Li, Cong Wang, Zhikui Liu, Shaoshan Han, Guozhi Yin, Kangsheng Tu, Qingguang Liu. MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma. Oncotarget 2017; 8(39) doi: 10.18632/oncotarget.20058
|
| 334 |
Dongdong Zhou, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Huiwen Yan, Yuyong Jiang, Zhiyun Yang. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07916-3
|
| 335 |
A. M. Aliyu, A. B. Olokoba, M. O. Bojuwoye, K. C. Okonkwo. The Combined Diagnostic Accuracy of Serum Alpha Fetoprotein and Des-Gamma Carboxyprothrombin in Hepatocellular Carcinoma among Chronic Liver Disease Patients in Ilorin. Open Journal of Gastroenterology 2021; 11(12) doi: 10.4236/ojgas.2021.1112026
|
| 336 |
Jiaxin Zhao, Cheng Wang, Liang Zhao, Huiying Zhou, Rui Wu, Tao Zhang, Jiawei Ding, Junjie Zhou, Huilin Zheng, Lei Zhang, Tianci Kong, Jie Zhou, Zhenhua Hu. A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation. Journal of Hepatocellular Carcinoma 2024; doi: 10.2147/JHC.S450711
|
| 337 |
Yu Akazawa, Toshihiro Suzuki, Toshiaki Yoshikawa, Shoichi Mizuno, Yasunari Nakamoto, Tetsuya Nakatsura. Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma. World Journal of Meta-Analysis 2019; 7(3): 80-95 doi: 10.13105/wjma.v7.i3.80
|
| 338 |
Muhammad Kamran, Aimun Raees, Wasim Jafri. Updates on the Diagnosis and Management of Hepatocellular Carcinoma. Euroasian Journal of Hepato-Gastroenterology 2021; 11(1) doi: 10.5005/jp-journals-10018-1335
|
| 339 |
Yunyang Xu, Jiarui Li, Xingyu Luo, Ze Xiang, Zhe Yang, Xuyong Wei, Xiao Xu, Jian Chen. Emerging role of proteomics in advancing diagnosis, prognosis, and treatment of liver cancer. Liver Research 2026; doi: 10.1016/j.livres.2026.04.002
|
| 340 |
Tianpeng Yang, Lu Huang, Jiale He, Lihong Luo, Weiting Guo, Huajian Chen, Xinyue Jiang, Li Huang, Shumei Ma, Xiaodong Liu. Establishment of diagnostic model and identification of diagnostic markers between liver cancer and cirrhosis based on multi‐chip and machine learning. Clinical and Experimental Pharmacology and Physiology 2024; 51(8) doi: 10.1111/1440-1681.13907
|
| 341 |
Ying-jie Gao, Shi-rong Li, Yuan Huang. An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1118152
|
| 342 |
Seung Hun Lee, Mi Soo Kim, Jeong Gyu Lee. Non-Viral Hepatocellular Carcinoma with Normal Alpha-Fetoprotein but Elevated CA19-9 in an Older Patient with Obesity: A Case Report. Korean Journal of Geriatrics & Gerontology 2025; 26(3) doi: 10.15656/kjgg.2025.26.3.147
|
| 343 |
Tasneem A. Gameel, Sherine Rady, Khaled A. ElBahnasy, Sanaa M. Kamal. Novel Biomarkers from genes in the apoptotic pathway for Prediction of HCC Progression using Association Rule Mining. Proceedings of the 2019 8th International Conference on Software and Information Engineering 2019; doi: 10.1145/3328833.3328863
|
| 344 |
Se-Yeol Rhyou, Jae-Chern Yoo. Automated ultrasonography of hepatocellular carcinoma using discrete wavelet transform based deep-learning neural network. Medical Image Analysis 2025; 101 doi: 10.1016/j.media.2025.103453
|
| 345 |
Weiyi Wang, Chao Wei. Advances in the early diagnosis of hepatocellular carcinoma. Genes & Diseases 2020; 7(3) doi: 10.1016/j.gendis.2020.01.014
|
| 346 |
Kailiang Zhao, Xiaoquan Zhou, Yuchun Xiao, Yanni Wang, Lu Wen. Research Progress in Alpha-fetoprotein-induced Immunosuppression of Liver Cancer. Mini-Reviews in Medicinal Chemistry 2022; 22(17) doi: 10.2174/1389557522666220218124816
|
| 347 |
Naoki Yagi, Toshihiro Suzuki, Shoichi Mizuno, Motohiro Kojima, Masashi Kudo, Motokazu Sugimoto, Shin Kobayashi, Naoto Gotohda, Genichiro Ishii, Tetsuya Nakatsura. Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis. Cancer Science 2022; 113(5) doi: 10.1111/cas.15313
|
| 348 |
Ting Song, Lili Wang, Bin Su, Weiping Zeng, Taiyi Jiang, Tong Zhang, Guizhen Sun, Hao Wu. Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma. Journal of International Medical Research 2020; 48(3) doi: 10.1177/0300060519889270
|
| 349 |
Hassnaa M. Ibrahim, Magdy Z. Elghannam, Om Ali Y. Elkhawaga, Ahmed M.A. El-Sokkary. Evaluation of serum alpha fetoprotein-L3 as an accuracy novel biomarker for the early diagnosis of hepatocellular carcinoma in Egyptian patients. Saudi Journal of Biological Sciences 2021; 28(10) doi: 10.1016/j.sjbs.2021.06.020
|
| 350 |
Ziwei Yin, Minqiang Lu, Rongdang Fu. Knockdown of FANCI suppresses hepatocellular carcinoma development via the PI3K/Akt/GSK-3β pathway. Heliyon 2025; 11(4) doi: 10.1016/j.heliyon.2025.e42731
|
| 351 |
Dongna Xie, Shengnan Jia, Nian Wang, Lianghai Hu. . Advances in Clinical Chemistry 2026; 132 doi: 10.1016/bs.acc.2026.01.001
|
| 352 |
Qing-Qing Luo, Qiao-Nan Li, Dan Cai, Song Jiang, Shao-Song Liu, Mao-Sheng Liu, Cong Lv, Jin-Ke Wang, Kun-He Zhang, Ting Wang. The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions. Journal of Hepatocellular Carcinoma 2024; doi: 10.2147/JHC.S443273
|
| 353 |
Iuliana Nenu, Teodora Maria Toadere, Ioan Topor, Andra Țichindeleanu, Daniela Andreea Bondor, Șerban Ellias Trella, Zeno Sparchez, Gabriela Adriana Filip. Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View. Biomedicines 2023; 11(10) doi: 10.3390/biomedicines11102623
|
| 354 |
|
| 355 |
Xiaoming Dai, Ruixue Huang, Sai Hu, Yao Zhou, Xiaoya Sun, Pucheng Gui, Zijian Yu, Pingkun Zhou. A novel miR-0308-3p revealed by miRNA-seq of HBV-positive hepatocellular carcinoma suppresses cell proliferation and promotes G1/S arrest by targeting double CDK6/Cyclin D1 genes. Cell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00382-7
|
| 356 |
Song Huang, Yuehong Cai, Xueqing Zhao, Xiaohong Du, Haijun Hu. Elevated P4HB expression in hepatocellular carcinoma and its role in UCA1-mediated malignant progression. Cellular Signalling 2025; 136 doi: 10.1016/j.cellsig.2025.112131
|
| 357 |
Xuan-Hai Do, Mai Thi Le, Thu Huyen Nguyen, Thanh Thien Le, Xuan-Hung Nguyen, Thanh Binh Mai, Thi My Nhung Hoang, Uyen Thi Trang Than. Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S409649
|
| 358 |
Wei-bin Zhang, Si-ze Hou, Yan-ling Chen, Feng Mao, Yi Dong, Jian-gang Chen, Wen-ping Wang. Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.862297
|
| 359 |
José M. Mato, Félix Elortza, Shelly C. Lu, Virginie Brun, Alberto Paradela, Fernando J. Corrales. Liver cancer-associated changes to the proteome: what deserves clinical focus?. Expert Review of Proteomics 2018; 15(9) doi: 10.1080/14789450.2018.1521277
|
| 360 |
Minami Yamauchi, Masamitsu Maekawa, Toshihiro Sato, Yu Sato, Masaki Kumondai, Mio Tsuruoka, Jun Inoue, Atsushi Masamune, Nariyasu Mano. Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma. Metabolites 2024; 14(9) doi: 10.3390/metabo14090513
|
| 361 |
Qi Liu, Yue Sun, Xiuwen Lan, Yue Zhu, Senqiu Qiao, Jingzeng Cai, Ziwei Zhang. Absence of Txnrd3 and its Interact Protein Anxa2 Promotes the Process of Liver Fibrosis and Development of Liver Cancer. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3928954
|
| 362 |
Jun Hyuek Yang, Hyun Soo Kim, Bon Kon Koo, Cheol Min Lee, Jong-Hyeon Jung, Young Rok Seo. Considerations of Human Health Risk Assessment in Chemical Accident: Suggestions from a Toxicogenomic Approach. Toxicology and Environmental Health Sciences 2018; 10(2) doi: 10.1007/s13530-018-0350-8
|
| 363 |
Nanni Hua, Anxian Chen, Chen Yang, Hui Dong, Xianglei He, Guoqing Ru, Xiangmin Tong, Feifei Zhou, Shibing Wang. The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma. Molecular Biology Reports 2022; 49(8) doi: 10.1007/s11033-022-07624-6
|
| 364 |
Lu Ding, Jiaqi Hu, Xing Liu, Junyi Zeng, Zhiwen Hu, Jing Chen, Kang Zhu, Hong Duan, Xiaolin Huang. Ultrasensitive dynamic light scattering immunodetection of alpha-fetoprotein using heptamer-amplified nanoparticle crosslinking aggregation. Microchimica Acta 2024; 191(7) doi: 10.1007/s00604-024-06437-7
|
| 365 |
Zhongjian Pu, Fei Ge, Yajun Wang, Ziyu Jiang, Shilin Zhu, Shukui Qin, Qijun Dai, Hua Liu, Haiqing Hua. Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic. Bioengineered 2021; 12(1) doi: 10.1080/21655979.2021.1932211
|
| 366 |
Thanh Hai Phan, Van Thien Chi Nguyen, Thu Thuy Thi Pham, Van-Chu Nguyen, Tan Dat Ho, Thi Mong Quynh Pham, Thanh-Huong Tran, Thanh Dat Nguyen, Nguyen Duy Khang Le, Trong-Hieu Nguyen, Minh-Long Duong, Hoai-Phuong Thi Bach, Van-Vu Kim, The-Anh Pham, Bao Toan Nguyen, Thanh Nhan Vo Nguyen, Thanh Dang Nguyen, Dung Thai Bieu Phu, Boi Hoan Huu Phan, Duy-Sinh Nguyen, Dinh-Kiet Truong, Thanh-Thuy Thi Do, Hoa Giang, Hoai-Nghia Nguyen, Minh-Duy Phan, Le Son Tran. Circulating DNA Methylation Profile Improves the Accuracy of Serum Biomarkers for the Detection Of Nonmetastatic Hepatocellular Carcinoma. Future Oncology 2022; 18(39) doi: 10.2217/fon-2022-1218
|
| 367 |
De‑Yong Gao, Yun Ling, Xiao‑Li Lou, Ying‑Ying Wang, Liang‑Ming Liu. GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer. Oncology Letters 2017; doi: 10.3892/ol.2017.7695
|
| 368 |
Petra Grbčić, Elitza Petkova Markova Car, Mirela Sedić. Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention. Current Medicinal Chemistry 2020; 27(39) doi: 10.2174/0929867326666190911115722
|
| 369 |
Salsabeel S. AL-Mosht, Mohamed G. Al-Fandi, Lina M. K. Al-Ebbini. Nanoarchitectonics of composite biosensor for early detection of hepatocellular carcinoma. Applied Physics A 2022; 128(6) doi: 10.1007/s00339-022-05673-z
|
| 370 |
Run-tian Ma, Xiao-bo Zhao, Xiao-yu Sun, Jia Liu, Wei Ha, Yan-ping Shi. A fluorescent molecularly imprinted device for the on-line analysis of AFP in human serum. Journal of Materials Chemistry B 2019; 7(40) doi: 10.1039/C9TB01331H
|
| 371 |
Yong Wang, Rongfen Gao, Jinpeng Li, Shaotao Tang, Shuai Li, Qiangsong Tong, Shiwang Li. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization. International Journal of Nanomedicine 2021; doi: 10.2147/IJN.S284560
|
| 372 |
Gayathri Chalikonda, Sekani Allen, Ramakrishna Vadde, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; doi: 10.1016/B978-0-323-98807-0.00008-9
|
| 373 |
Xiaojiang Zhou, Lin Yang, Jingjing Deng, Wankai Guo, Di Liu, Jianfeng Zhou, Chuan Xu. The role of squamous cell carcinoma antigen and cytokeratin 19 fragment in predicting the outcome of esophageal cancer patients: insights from a meta-analysis. World Journal of Surgical Oncology 2025; 23(1) doi: 10.1186/s12957-025-03776-4
|
| 374 |
Kalyani Dasari. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00012-X
|
| 375 |
Dina Farinha, Ana Bela Sarmento-Ribeiro, Henrique Faneca. From conventional therapy to treatment with lipid-polymer hybrid nanoparticles for hepatocellular carcinoma. Materials Today Chemistry 2025; 47 doi: 10.1016/j.mtchem.2025.102870
|
| 376 |
Jian-Yao Wang, Xiang-Kun Wang, Guang-Zhi Zhu, Xin Zhou, Jun Yao, Xiao-Peng Ma, Bin Wang, Tao Peng. Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08104-z
|
| 377 |
Shan Gao, Wei Hu, Xin Huang, Xingyue Huang, Wenwei Chen, Lidan Hao, Zubing Chen, Jian Wang, Hailiang Wei. Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression. Cellular Signalling 2020; 72 doi: 10.1016/j.cellsig.2020.109621
|
| 378 |
Kuntay Kaplan, Yavuzalp Solak. Evaluation of YouTube Videos on Hepatocellular Carcinoma. Journal of Korean Medical Science 2023; 38(7) doi: 10.3346/jkms.2023.38.e50
|
| 379 |
Seyed Mohammad Mahdi Dadfar, Sylwia Sekula-Neuner, Vanessa Trouillet, Hui-Yu Liu, Ravi Kumar, Annie K Powell, Michael Hirtz. Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP). Beilstein Journal of Nanotechnology 2019; 10 doi: 10.3762/bjnano.10.241
|
| 380 |
Pedram Asadi Sarabi, Elham Rismani, Amir Ali Judaki, Amirhossein Farrokhzad, Zahra Hendi, Moustapha Hassan, Massoud Vosough, Priyanka Sharma. Extracellular Matrix–Associated Biomarkers for Hepatocellular Carcinoma: Insights From Machine Learning and Single‐Cell Analysis. International Journal of Genomics 2026; 2026(1) doi: 10.1155/ijog/6654142
|
| 381 |
Arezoo Gowhari Shabgah, Fatemeh Ezzatifar, Surendar Aravindhan, Angelina Olegovna Zekiy, Majid Ahmadi, Seyed Mohammad Gheibihayat, Jamshid Gholizadeh Navashenaq. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy. IUBMB Life 2021; 73(4) doi: 10.1002/iub.2458
|
| 382 |
Johanna K. DiStefano. Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma. Non-coding RNA Research 2017; 2(3-4) doi: 10.1016/j.ncrna.2017.11.001
|
| 383 |
William B. Coleman, Gregory J. Tsongalis. Diagnostic Molecular Pathology. 2024; doi: 10.1016/B978-0-12-822824-1.00047-X
|
| 384 |
Abdulrahman Hatawsh, Roya Hadi Al-Haddad, Ukamaka Gladys Okafor, Lamis M. Diab, Nino Dekanoidze, Adeniyi Ayinde Abdulwahab, Osama A. Mohammed, Ahmed S. Doghish, Rewan Moussa, Hanan Elimam. Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma. Medical Oncology 2024; 41(12) doi: 10.1007/s12032-024-02538-8
|
| 385 |
Chenfang Sun, Yi-Xuan Wang, Mingyuan Sun, Ye Zou, Congcong Zhang, Shanshan Cheng, Wenping Hu. Facile and cost-effective liver cancer diagnosis by water-gated organic field-effect transistors. Biosensors and Bioelectronics 2020; 164 doi: 10.1016/j.bios.2020.112251
|
| 386 |
Abeer Mohsin, Kanwal Haneef, Amber Ilyas, Shamshad Zarina, Zehra Hashim. Oxidative Stress Induced Cell Cycle Arrest: Potential Role of PRX-2 and
GSTP-1 as Therapeutic Targets in Hepatocellular Carcinoma. Protein & Peptide Letters 2021; 28(12) doi: 10.2174/0929866528666211105105953
|
| 387 |
Junqi Wang, Ke Yang, Xin Yang, Tianqiang Jin, Yu Tian, Chaoliu Dai, Feng Xu. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway. Molecular Carcinogenesis 2024; 63(7) doi: 10.1002/mc.23723
|
| 388 |
Faris Alrumaihi. Role of Liquid Biopsy for Early Detection, Prognosis, and Therapeutic Monitoring of Hepatocellular Carcinoma. Diagnostics 2025; 15(13) doi: 10.3390/diagnostics15131655
|
| 389 |
Yunxun Liu, Bingbing Shen, Ting Huang, Jianguo Wang, Jianxin Jiang, Muhammad Tarek Abdel Ghafar. Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients. PLOS ONE 2023; 18(7) doi: 10.1371/journal.pone.0288013
|
| 390 |
Wenli Liu, Kaiheng Hu, Yaqing Fu, Tianmin Zhou, Qingmei Zhong, Wu Wang, Yang Gui, Ping Zhang, Di Yao, Xiaohong Yang, Weifeng Zhu, Zhuoqi Liu, Daya Luo, Yingqun Xiao. Identification of methionine metabolism related prognostic model and tumor suppressive functions of BHMT in hepatocellular carcinoma. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-93650-w
|
| 391 |
Yehia I. Mohamed, Sunyoung S. Lee, Tarik Demir, Shadi Chamseddine, Zishuo Ian Hu, Lianchun Xiao, Khaled Elsayes, Jeffrey S. Morris, Robert A. Wolff, Rikita Hiatia, Aliya Qayyum, Asif Rashid, Dan G. Duda, James C. Yao, Michael LaPelusa, Eugene J. Koay, Armeen Mahvash, Ahmed Al Azzam, Ecaterina E. Dumbrava, Manal Hassan, Hesham M. Amin, Ahmed Omar Kaseb. Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab. Cancer Biomarkers 2024; 41(1) doi: 10.3233/CBM-230431
|
| 392 |
Yichen Yang, Yuequn Ma, Meng Yuan, Yonglin Peng, Zhonghai Fang, Ju Wang. Identifying the biomarkers and pathways associated with hepatocellular carcinoma based on an integrated analysis approach. Liver International 2021; 41(10) doi: 10.1111/liv.14972
|
| 393 |
Merricka C. Livingstone, Natalie M. Johnson, Bill D. Roebuck, Thomas W. Kensler, John D. Groopman. Serum miR‐182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats. Molecular Carcinogenesis 2019; 58(11) doi: 10.1002/mc.23093
|
| 394 |
Na Hu, Yuhui Wu, Maowen Tang, Tianyong Luo, Shengmei Yuan, Cai Li, Pinggui Lei. Case report: Hepatic tuberculosis mimicking hepatocellular carcinoma in a patient with cirrhosis induced by hepatitis B virus. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1005680
|
| 395 |
H. M. M. T. B. Herath, Aruna Kulatunga. Large hepatocellular carcinoma in a non-cirrhotic liver with peritoneal and omental metastasis in a healthy man: a case report. Journal of Medical Case Reports 2017; 11(1) doi: 10.1186/s13256-017-1203-9
|
| 396 |
Kareem A. Attallah, Khaled Farid, Mohamed S. Albannan. Revolutionizing early HCC detection: groundbreaking validation of the HCC-check index for small tumors in Egyptian patients using CLIP and BCLC staging systems. Medical Oncology 2025; 42(7) doi: 10.1007/s12032-025-02834-x
|
| 397 |
Mahdokht Kohansal-Nodehi, Magdalena Swiatek-de Lange, Konstantin Kroeniger, Vinzent Rolny, Glòria Tabarés, Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Henry Lik-Yuen Chan, Holger Busskamp. Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1213898
|
| 398 |
Yukun Bai, Ping Wang, Yanwei Qi, Yang Li, Weidong Liu, Lei Gao, Hanliang Jiao, Yanxiao An, Yingxin Gong. Diagnostic value of HA, PC-III, IV-C, and LN in infants with congenital biliary atresia. Medicine 2022; 101(32) doi: 10.1097/MD.0000000000029752
|
| 399 |
Jia-Mei Dong, Rui-Qi Wang, Ning-Ning Yuan, Jia-Hao Guo, Xin-Yang Yu, Ang-Hui Peng, Jia-Yi Cai, Lei Xue, Zhi-Ling Zhou, Yi-Hao Sun, Ying-Yin Chen. Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1160544
|
| 400 |
Zhuoyan Chen, Yuan Zeng, Peipei Ma, Qian Xu, Liuwei Zeng, Xian Song, Fujun Yu. Integrated GMPS and RAMP3 as a signature to predict prognosis and immune heterogeneity in hepatocellular carcinoma. Gene 2025; 933 doi: 10.1016/j.gene.2024.148958
|
| 401 |
Olga Y. Burenina, Natalia L. Lazarevich, Inna F. Kustova, Daria A. Shavochkina, Ekaterina A. Moroz, Nikolay E. Kudashkin, Yuriy I. Patyutko, Alexey V. Metelin, Eduard F. Kim, Dmitry A. Skvortsov, Timofei S. Zatsepin, Maria P. Rubtsova, Olga A. Dontsova. Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors. Journal of Cancer Research and Clinical Oncology 2021; 147(1) doi: 10.1007/s00432-020-03378-5
|
| 402 |
Archu Singh, Sadat Shafi, Tanya Upadhyay, Abul Kalam Najmi, Kanchan Kohli, Faheem Hyder Pottoo. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment. Current Topics in Medicinal Chemistry 2020; 20(20) doi: 10.2174/1568026620666200624161801
|
| 403 |
Soroosh Sabeti, Redouane Ternifi, Nicholas B. Larson, Michael C. Olson, Thomas D. Atwell, Mostafa Fatemi, Azra Alizad. Morphometric analysis of tumor microvessels for detection of hepatocellular carcinoma using contrast-free ultrasound imaging: A feasibility study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1121664
|
| 404 |
Yang Yang, Wei Yang, Jie Shen, Enci Ding. Integrated transcriptomics and proteomics analysis of the impact of iodine‑125 in hepatocellular carcinoma. Molecular Medicine Reports 2025; 31(3) doi: 10.3892/mmr.2025.13431
|
| 405 |
Danli Yang, Mingjie Yao, Ying Yan, Yanna Liu, Xiajie Wen, Xiangmei Chen, Fengmin Lu. Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease. Biomolecules 2021; 11(2) doi: 10.3390/biom11020205
|
| 406 |
Xiangyan Xiao, Qiyuan Huang, Xiaocong Lin, Kashif Rafiq Zahid, Xueran Huang, Tiancai Liu, Tao Zeng. Current methods for the detection of glypican-3. Analytical Methods 2024; 16(2) doi: 10.1039/D3AY01523H
|
| 407 |
Wenqing Cao, Meenal Sharma, Rami Imam, Jiangzhou Yu. Study on Diagnostic Values of Astrocyte Elevated Gene 1 (AEG-1) and Glypican 3 (GPC-3) in Hepatocellular Carcinoma. American Journal of Clinical Pathology 2019; 152(5) doi: 10.1093/ajcp/aqz086
|
| 408 |
Yucel Aydin, Ali Riza Koksal, Paul Thevenot, Srinivas Chava, Zahra Heidari, Dong Lin, Tyler Sandow, Krzysztof Moroz, Mansour A Parsi, John Scott, Ari Cohen, Srikanta Dash. Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S327339
|
| 409 |
Dan Wang, Baolan Wan, Xiaojing Zhang, Pingping Sun, Shu Lu, Chenxu Liu, Li Zhu. Nuclear respiratory factor 1 promotes the growth of liver hepatocellular carcinoma cells via E2F1 transcriptional activation. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02260-7
|
| 410 |
Tommaso A. Dragani, Valerie Matarese, Francesca Colombo. Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics. BioEssays 2020; 42(4) doi: 10.1002/bies.201900122
|
| 411 |
Wenbiao Chen, Donge Tang, Minglin Ou, Yong Dai. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes. DNA and Cell Biology 2020; 39(4) doi: 10.1089/dna.2019.5099
|
| 412 |
Dongxia Li, Lizhen Zeng, Yuanli Wang, Hong-Wen Tang, Wen Xing Lee, Zhencheng Chen, Longhui Zhang, Yingchang Zou, Duan Xie, Fangrong Hu. Terahertz metamaterial biosensor for diagnosis of hepatocellular carcinoma at early stage. Applied Optics 2022; 61(16) doi: 10.1364/AO.459489
|
| 413 |
Chetna Gupta, Himanshu Yadav, Ishika Dhanwani, Shikha Gulati. Theranostic Applications of Tailored Lipid-based Nanoparticles as Drug Delivery Systems for Cancer Treatment. ACS Applied Nano Materials 2025; 8(41) doi: 10.1021/acsanm.5c03503
|
| 414 |
Francisco Cezar Aquino de Moraes, Vitor Kendi Tsuchiya Sano, Caroline R M Pereira, Jamile Cristine Marques Barros, Rommel Mario Rodríguez Burbano. Vitamin K2 Supplementation and Clinical Outcomes in Hepatocellular Carcinoma Patients: A Meta-Analysis with Trial Sequential Analysis. Nutrition and Cancer 2026; 78(3) doi: 10.1080/01635581.2025.2600102
|
| 415 |
Biyuan Luo, Fang Ma, Hao Liu, Jixiong Hu, Le Rao, Chun Liu, Yongfang Jiang, Shuyu Kuangzeng, Xuan Lin, Chenyang Wang, Yiyu Lei, Zhongzhou Si, Guangshun Chen, Ning Zhou, Chengbai Liang, Fangqing Jiang, Fenge Liu, Weidong Dai, Wei Liu, Yawen Gao, Zhihong Li, Xi Li, Guangyu Zhou, Bingsi Li, Zhihong Zhang, Weiqi Nian, Lihua Luo, Xianling Liu. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma. BMC Medicine 2022; 20(1) doi: 10.1186/s12916-021-02201-3
|
| 416 |
Shi-Tao Wu, Li Zhu, Xiao-Ling Feng, Hao-Yu Wang, Fang Li. Strategies for discovering novel hepatocellular carcinoma biomarkers. World Journal of Hepatology 2025; 17(2): 101201 doi: 10.4254/wjh.v17.i2.101201
|
| 417 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5) doi: 10.3390/ijms24054286
|
| 418 |
Yi Jiang, Lu Guo, Lei Han, Han Li, Changlun Li, Lianbin Wen, Yanqiong Song, Zhaoyang Wang, Pan Wang, Qulian Guo, Wenxi Zhao, Mengxiang Liu, Jiali Chen, Zhenying Wu, Yushan Yan, Ke Xu, Tao Gu, Xue Wu, Kun He, Ke Su, Yunwei Han. Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study. Journal of Cancer Research and Clinical Oncology 2023; 149(15) doi: 10.1007/s00432-023-05089-z
|
| 419 |
Mona A. Omar, Mohamed M. Omran, Khaled Farid, Ashraf A. Tabll, Yasser E. Shahein, Tarek M. Emran, Ana Petrovic, Nikola R. Lucic, Robert Smolic, Tanja Kovac, Martina Smolic. Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis. Biomedicines 2023; 11(7) doi: 10.3390/biomedicines11071852
|
| 420 |
Yalei Zhao, Chen Xue, Zhongyang Xie, Xiaoxi Ouyang, Lanjuan Li. Comprehensive analysis of ubiquitin‐specific protease 1 reveals its importance in hepatocellular carcinoma. Cell Proliferation 2020; 53(10) doi: 10.1111/cpr.12908
|
| 421 |
Krishana Kumar Sharma, Mohd. Mohsin, Piyush Mittal, Zeeshan Ali, Nishat Fatma, Prashant Upadhyay, Ritu Gupta, Anurag Verma, Gajendra Kumar. Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review. Current Pharmaceutical Design 2024; 30(22) doi: 10.2174/0113816128298875240321073907
|
| 422 |
Junsheng Zhao, Sijia Shen, Junjie Zhang, Ying Xu, Jing Peng, Hainv Gao, Lanjuan Li. Whole‐Genome Bisulfite Sequencing Identifies Blood‐Based DNA Methylation Biomarker for Hepatocellular Carcinoma. Molecular Carcinogenesis 2026; 65(5) doi: 10.1002/mc.70101
|
| 423 |
Mohamed M. Omran, Khaled Farid, Mona A. Omar, Tarek M. Emran, Fathy M. El-Taweel, Ashraf A. Tabll. A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma. Annals of Hepatology 2020; 19(2) doi: 10.1016/j.aohep.2019.09.002
|
| 424 |
Se-Yeol Rhyou, Minyung Yu, Jae-Chern Yoo. Mixture of Expert-Based SoftMax-Weighted Box Fusion for Robust Lesion Detection in Ultrasound Imaging. Diagnostics 2025; 15(5) doi: 10.3390/diagnostics15050588
|
| 425 |
Jing Tang, Yunxia Wang, Yongchao Luo, Jianbo Fu, Yang Zhang, Yi Li, Ziyu Xiao, Yan Lou, Yunqing Qiu, Feng Zhu. Computational advances of tumor marker selection and sample classification in cancer proteomics. Computational and Structural Biotechnology Journal 2020; 18 doi: 10.1016/j.csbj.2020.07.009
|
| 426 |
Lijie Xia, Qiao Teng, Qi Chen, Fuchun Zhang. <p>Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma</p>. International Journal of Nanomedicine 2020; doi: 10.2147/IJN.S235058
|
| 427 |
Yi Shi, Jingrui Men, Hongliang Sun, Jianjun Tan. The Identification and Analysis of MicroRNAs Combined Biomarkers for
Hepatocellular Carcinoma Diagnosis. Medicinal Chemistry 2022; 18(10) doi: 10.2174/1573406418666220404084532
|